{
  "metadata": {
    "schema_version": "3.5-hybrid",
    "generated_on": "2026-01-19",
    "description": "Hybrid pillars taxonomy combining MAPS-aligned strategic constraints with tactical variant intelligence and probabilistic modeling for Medical Affairs Intelligence Platform (expanded: full pillar implementations generated for all indexed pillars)",
    "design_philosophy": "Merge deterministic MAPS compliance (v3.0) with contextual tactical variants (v2.0) for both strategic planning and simulation",
    "alignment_frameworks": [
      "MAPS_iMC_Strategy_and_Plan",
      "MAPS_Strategic_Medical_Planning",
      "MAPS_Launch_Excellence"
    ],
    "model_runtime_target": "gpt-4.1 / claude-sonnet-4",
    "regions_in_scope": [
      "UK",
      "EU",
      "US",
      "Eastern_Europe",
      "LATAM",
      "SE_Asia_Emerging",
      "Middle_East"
    ],
    "design_principles": [
      "Strategy expressed as constraints (eligible tactics, measurement requirements, lifecycle windows)",
      "Explicit cascades with tactical variant intelligence",
      "Region archetypes with bounded overrides and regional modifiers",
      "Probabilistic priority weighting for Monte Carlo simulation",
      "Contextual tactic selection based on stakeholder attributes",
      "Resource estimation and ROI modeling capabilities"
    ],
    "simulation_capabilities": {
      "monte_carlo_ready": true,
      "resource_modeling_ready": true,
      "roi_simulation_ready": true,
      "tactical_optimization_ready": true
    }
  },
  "enums": {
    "priority_level": [
      "low",
      "medium",
      "high",
      "very_high",
      "critical"
    ],
    "lifecycle_phase": [
      "prelaunch_T-48_to_T-24",
      "perilaunch_T-24_to_T-12",
      "launch_T-12_to_T0",
      "postlaunch_T0_to_T12",
      "beyond_T12"
    ],
    "evidence_dependency": [
      "none",
      "supportive",
      "required"
    ],
    "metric_level": [
      "activity",
      "output",
      "outcome",
      "impact"
    ],
    "confidence_level": [
      "very_low",
      "low",
      "medium",
      "high",
      "very_high"
    ],
    "channel_family": [
      "field_scientific_exchange",
      "scientific_publications",
      "congress",
      "medical_education",
      "digital_scientific_platform",
      "internal_enablement",
      "payer_value_communication",
      "patient_advocacy_engagement"
    ],
    "tactic_family": [
      "scientific_exchange",
      "insight_generation",
      "evidence_generation",
      "evidence_dissemination",
      "medical_education",
      "digital_omnichannel",
      "publication_strategy",
      "advisory_boards",
      "market_access_value",
      "patient_advocacy",
      "internal_enablement",
      "data_partnership"
    ],
    "governance_gate": [
      "draft",
      "mlr_review",
      "approved",
      "sunset",
      "retired"
    ],
    "pillar_dependency_type": [
      "prerequisite",
      "synergistic",
      "sequential",
      "concurrent"
    ]
  },
  "weighting_system": {
    "base_formula": "final_priority = base_priority × lifecycle_modifier × therapy_modifier × region_modifier × resource_availability × evidence_readiness",
    "priority_ranges": {
      "critical": [
        0.9,
        1.0
      ],
      "very_high": [
        0.75,
        0.89
      ],
      "high": [
        0.6,
        0.74
      ],
      "medium": [
        0.4,
        0.59
      ],
      "low": [
        0.2,
        0.39
      ]
    },
    "simulation_parameters": {
      "monte_carlo_iterations_default": 10000,
      "probability_distribution": "beta",
      "correlation_modeling": true
    }
  },
  "modifiers": {
    "lifecycle_phase_modifier": {
      "description": "Multiplier based on pillar relevance to current lifecycle phase",
      "prelaunch_T-48_to_T-24": {
        "evidence_generation": 1.3,
        "kol_engagement": 1.25,
        "publications": 1.2,
        "market_access_support": 1.15,
        "hcp_education": 0.7
      },
      "perilaunch_T-24_to_T-12": {
        "evidence_generation": 1.25,
        "kol_engagement": 1.3,
        "publications": 1.25,
        "market_access_support": 1.3,
        "hcp_education": 0.9
      },
      "launch_T-12_to_T0": {
        "evidence_generation": 1.1,
        "kol_engagement": 1.35,
        "publications": 1.2,
        "market_access_support": 1.35,
        "hcp_education": 1.3,
        "field_medical": 1.25
      },
      "postlaunch_T0_to_T12": {
        "scientific_exchange": 1.3,
        "hcp_education": 1.35,
        "field_medical": 1.3,
        "rwe_generation": 1.25,
        "publications": 1.15
      },
      "beyond_T12": {
        "rwe_generation": 1.3,
        "scientific_exchange": 1.2,
        "evidence_interpretation": 1.15,
        "data_analytics": 1.2
      }
    },
    "therapy_area_modifier": {
      "description": "Multiplier based on therapy area characteristics",
      "rare_disease": {
        "kol_engagement": 1.4,
        "patient_advocacy": 1.35,
        "market_access_support": 1.3
      },
      "oncology": {
        "evidence_generation": 1.3,
        "kol_engagement": 1.25,
        "publications": 1.25
      },
      "gene_therapy": {
        "evidence_generation": 1.35,
        "market_access_support": 1.4,
        "hcp_education": 1.3
      }
    },
    "region_modifier": {
      "description": "Multiplier based on regional strategic importance",
      "US": {
        "publications": 1.2,
        "market_access_support": 1.25,
        "compliance_governance": 1.3
      },
      "EU": {
        "kol_engagement": 1.15,
        "market_access_support": 1.2,
        "publications": 1.15
      },
      "Eastern_Europe": {
        "field_medical": 1.2,
        "patient_advocacy": 1.15
      }
    }
  },
  "cascade_contract": {
    "description": "Defines how pillars cascade constraints to tactics, metrics, and stakeholders",
    "canonical_link_fields": {
      "tactic_families": {
        "target": "tactics.json",
        "mechanism": "cascade.eligible_tactic_families filters available tactics; cascade.tactical_variants provides contextual guidance"
      },
      "metric_levels": {
        "target": "metrics.json",
        "mechanism": "cascade.supported_metric_levels and cascade.minimum_metric_level_required bound measurement claims"
      },
      "stakeholder_categories": {
        "target": "stakeholders.json",
        "mechanism": "cascade.primary_stakeholder_category_keys and cascade.secondary_stakeholder_category_keys filter stakeholder engagement"
      },
      "pillar_dependencies": {
        "target": "execution_plans.json",
        "mechanism": "pillar_dependencies graph enables sequencing and resource optimization"
      }
    },
    "required_pillar_fields": [
      "id",
      "title",
      "maps_strategy.strategic_intent",
      "maps_strategy.scientific_narrative.core_claim",
      "maps_strategy.lifecycle.relevant_phases",
      "cascade.eligible_tactic_families",
      "cascade.minimum_metric_level_required",
      "cascade.minimum_confidence_required",
      "priority_weighting.base_priority",
      "tactical_variants"
    ]
  },
  "pillar_index": {
    "evidence_generation": {
      "title": "Evidence Generation",
      "base_priority": "high",
      "lifecycle_relevance": [
        "prelaunch_T-48_to_T-24",
        "perilaunch_T-24_to_T-12",
        "launch_T-12_to_T0",
        "postlaunch_T0_to_T12"
      ]
    },
    "evidence_interpretation": {
      "title": "Evidence Interpretation & Synthesis",
      "base_priority": "medium",
      "lifecycle_relevance": [
        "prelaunch_T-48_to_T-24",
        "perilaunch_T-24_to_T-12",
        "launch_T-12_to_T0",
        "postlaunch_T0_to_T12",
        "beyond_T12"
      ]
    },
    "scientific_exchange": {
      "title": "Scientific Exchange",
      "base_priority": "high",
      "lifecycle_relevance": [
        "perilaunch_T-24_to_T-12",
        "launch_T-12_to_T0",
        "postlaunch_T0_to_T12",
        "beyond_T12"
      ]
    },
    "publications": {
      "title": "Scientific Publications",
      "base_priority": "high",
      "lifecycle_relevance": [
        "prelaunch_T-48_to_T-24",
        "perilaunch_T-24_to_T-12",
        "launch_T-12_to_T0",
        "postlaunch_T0_to_T12"
      ]
    },
    "kol_engagement": {
      "title": "KOL Engagement & Advocacy",
      "base_priority": "very_high",
      "lifecycle_relevance": [
        "prelaunch_T-48_to_T-24",
        "perilaunch_T-24_to_T-12",
        "launch_T-12_to_T0",
        "postlaunch_T0_to_T12"
      ]
    },
    "hcp_education": {
      "title": "HCP Education",
      "base_priority": "high",
      "lifecycle_relevance": [
        "launch_T-12_to_T0",
        "postlaunch_T0_to_T12",
        "beyond_T12"
      ]
    },
    "patient_advocacy": {
      "title": "Patient Advocacy & Insights",
      "base_priority": "medium",
      "lifecycle_relevance": [
        "prelaunch_T-48_to_T-24",
        "perilaunch_T-24_to_T-12",
        "launch_T-12_to_T0",
        "postlaunch_T0_to_T12",
        "beyond_T12"
      ]
    },
    "market_access_support": {
      "title": "Market Access Support",
      "base_priority": "very_high",
      "lifecycle_relevance": [
        "prelaunch_T-48_to_T-24",
        "perilaunch_T-24_to_T-12",
        "launch_T-12_to_T0",
        "postlaunch_T0_to_T12"
      ]
    },
    "digital_omnichannel": {
      "title": "Digital & Omnichannel Engagement",
      "base_priority": "medium",
      "lifecycle_relevance": [
        "launch_T-12_to_T0",
        "postlaunch_T0_to_T12",
        "beyond_T12"
      ]
    },
    "field_medical": {
      "title": "Field Medical Excellence",
      "base_priority": "high",
      "lifecycle_relevance": [
        "launch_T-12_to_T0",
        "postlaunch_T0_to_T12",
        "beyond_T12"
      ]
    },
    "internal_alignment": {
      "title": "Internal Alignment & Training",
      "base_priority": "medium",
      "lifecycle_relevance": [
        "prelaunch_T-48_to_T-24",
        "perilaunch_T-24_to_T-12",
        "launch_T-12_to_T0"
      ]
    },
    "compliance_governance": {
      "title": "Compliance & Governance",
      "base_priority": "critical",
      "lifecycle_relevance": [
        "prelaunch_T-48_to_T-24",
        "perilaunch_T-24_to_T-12",
        "launch_T-12_to_T0",
        "postlaunch_T0_to_T12",
        "beyond_T12"
      ]
    },
    "data_analytics": {
      "title": "Data & Analytics Enablement",
      "base_priority": "medium",
      "lifecycle_relevance": [
        "prelaunch_T-48_to_T-24",
        "perilaunch_T-24_to_T-12",
        "launch_T-12_to_T0",
        "postlaunch_T0_to_T12",
        "beyond_T12"
      ]
    },
    "congress_presence": {
      "title": "Congress Presence & Planning",
      "base_priority": "high",
      "lifecycle_relevance": [
        "prelaunch_T-48_to_T-24",
        "perilaunch_T-24_to_T-12",
        "launch_T-12_to_T0",
        "postlaunch_T0_to_T12"
      ]
    },
    "rwe_generation": {
      "title": "Real-World Evidence (RWE) Generation",
      "base_priority": "high",
      "lifecycle_relevance": [
        "postlaunch_T0_to_T12",
        "beyond_T12"
      ]
    }
  },
  "pillars": [
    {
      "id": "evidence_generation",
      "title": "Evidence Generation",
      "description": "Design, execute, and manage clinical and non-clinical studies to generate evidence supporting product value proposition and addressing evidence gaps",
      "tags": [
        "clinical_trials",
        "studies",
        "research",
        "data_generation"
      ],
      "maps_strategy": {
        "strategic_intent": "Build comprehensive evidence base to support regulatory approval, market access, and clinical adoption through systematic data generation aligned with unmet evidence needs",
        "scientific_narrative": {
          "core_claim": "Systematic evidence generation addressing critical knowledge gaps and supporting product differentiation",
          "supporting_messages": [
            "Rigorous study design addressing key clinical and economic questions",
            "Evidence aligned with regulatory, payer, and clinical stakeholder needs",
            "Prospective data generation to complement existing evidence base"
          ],
          "data_of_interest": [
            "Clinical trial data (efficacy, safety, QoL)",
            "Health economics data (cost-effectiveness, budget impact)",
            "Patient-reported outcomes",
            "Biomarker and mechanistic data"
          ],
          "differentiators": [
            "Evidence quality and regulatory grade",
            "Comprehensive endpoints addressing multiple stakeholder needs",
            "Innovative trial designs (adaptive, pragmatic)"
          ],
          "channel_families": [
            "scientific_publications",
            "congress",
            "field_scientific_exchange"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "prelaunch_T-48_to_T-24",
            "perilaunch_T-24_to_T-12",
            "launch_T-12_to_T0",
            "postlaunch_T0_to_T12"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Focus on pivotal trial design and execution; early evidence generation for regulatory submissions",
            "perilaunch_T-24_to_T-12": "Complete pivotal studies; initiate post-hoc analyses and supplementary studies",
            "launch_T-12_to_T0": "Finalize study reports; prepare for publication and dissemination",
            "postlaunch_T0_to_T12": "Conduct confirmatory studies and address emerging evidence gaps"
          }
        },
        "evidence": {
          "evidence_dependency": "required",
          "evidence_gaps": [
            "Head-to-head comparator data",
            "Long-term safety and efficacy",
            "Special population data (pediatric, elderly, comorbidities)",
            "Cost-effectiveness in target markets"
          ],
          "prioritized_questions": [
            "What clinical endpoints matter most to regulators, payers, and clinicians?",
            "What study designs provide most credible evidence for stakeholder needs?",
            "How can we generate evidence efficiently while maintaining quality?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "high",
        "base_priority_score": 0.75,
        "priority_distribution": {
          "mean": 0.75,
          "stddev": 0.1,
          "min": 0.55,
          "max": 0.95,
          "confidence_level": "high"
        },
        "dynamic_priority_factors": {
          "evidence_gap_criticality": {
            "weight": 0.3,
            "measurement": "Number and severity of critical evidence gaps"
          },
          "regulatory_requirement": {
            "weight": 0.25,
            "measurement": "Regulatory mandate for additional evidence"
          },
          "competitive_positioning": {
            "weight": 0.2,
            "measurement": "Need for comparative evidence vs competitors"
          },
          "payer_evidence_demand": {
            "weight": 0.15,
            "measurement": "Payer requirements for reimbursement"
          },
          "resource_availability": {
            "weight": 0.1,
            "measurement": "Budget and operational capacity for studies"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "evidence_generation",
          "insight_generation",
          "data_partnership",
          "advisory_boards"
        ],
        "ineligible_tactic_families": [
          "medical_education",
          "digital_omnichannel"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "output",
        "minimum_confidence_required": "medium",
        "primary_stakeholder_category_keys": [
          "academia_research",
          "external_experts",
          "regulators"
        ],
        "secondary_stakeholder_category_keys": [
          "market_access_payers",
          "data_tech_partners"
        ],
        "cascade_probability_weights": {
          "evidence_generation": 0.95,
          "advisory_boards": 0.75,
          "data_partnership": 0.7
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "Real-time data streaming studies",
              "API-integrated patient registries",
              "Blockchain-verified study protocols",
              "AI-powered patient matching",
              "Decentralized clinical trials"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.3
          },
          "digital_adopter": {
            "tactics": [
              "Electronic data capture (EDC) systems",
              "Virtual study monitoring",
              "Digital consent processes",
              "Hybrid trial designs",
              "Remote patient monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.1
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional CRF with digital backup",
              "Phone-based patient follow-up",
              "Paper-digital hybrid systems",
              "In-person site visits",
              "Conventional monitoring"
            ],
            "applicability_score": 0.6,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "offline_only": {
            "tactics": [
              "Paper-based data collection",
              "Postal patient surveys",
              "In-person interviews only",
              "Traditional statistical analysis",
              "Physical site monitoring"
            ],
            "applicability_score": 0.4,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "FDA-preapproved study protocols",
              "Independent data monitoring committee",
              "Third-party statistical analysis",
              "Full audit trail documentation",
              "GCP-compliant operations"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.4
          },
          "high": {
            "tactics": [
              "IRB-approved protocols",
              "Regular compliance monitoring",
              "Standard audit procedures",
              "Documentation requirements",
              "Quality assurance protocols"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "medium": {
            "tactics": [
              "Standard ethical approval",
              "Routine monitoring",
              "Basic documentation",
              "Standard reporting",
              "Internal QA reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Minimal approval requirements",
              "Self-monitoring protocols",
              "Streamlined documentation",
              "Simplified reporting",
              "Basic oversight"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_data_sensitivity": {
          "very_high": {
            "tactics": [
              "De-identification at source",
              "Encrypted data transmission",
              "Secure multi-party computation",
              "Zero-knowledge proof protocols",
              "Federated learning approaches"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.35
          },
          "high": {
            "tactics": [
              "Pseudonymization protocols",
              "Encrypted databases",
              "Access control systems",
              "Regular security audits",
              "Privacy-preserving analytics"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "high",
            "cost_multiplier": 1.15
          },
          "medium": {
            "tactics": [
              "Standard data protection",
              "Basic encryption",
              "User authentication",
              "Periodic reviews",
              "Standard privacy measures"
            ],
            "applicability_score": 0.65,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Basic anonymization",
              "Standard security",
              "Simple access controls",
              "Minimal restrictions",
              "Standard data handling"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_cross_border": {
          "restricted": {
            "tactics": [
              "Country-specific protocols",
              "Local PI requirements",
              "Regional data centers",
              "Jurisdiction-specific approvals",
              "Local ethics committees"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "unrestricted": {
            "tactics": [
              "Global protocol harmonization",
              "Central data management",
              "Unified approval processes",
              "Cross-border data sharing",
              "International coordination"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 500000,
          "typical": 2000000,
          "max": 10000000
        },
        "resource_requirements": {
          "ftes": {
            "clinical_operations_lead": 0.5,
            "clinical_project_manager": 1.0,
            "clinical_research_associates": 2.0,
            "data_manager": 0.5,
            "medical_monitor": 0.25,
            "biostatistician": 0.3
          },
          "external_vendors": [
            "CRO (clinical research organization)",
            "central_lab",
            "imaging_core_lab",
            "data_management_vendor"
          ]
        },
        "timeline_estimate_months": {
          "min": 12,
          "typical": 24,
          "max": 48
        },
        "roi_metrics": {
          "primary": "evidence_quality_score",
          "secondary": [
            "regulatory_approval_acceleration",
            "payer_coverage_probability",
            "publication_impact_factor"
          ],
          "expected_roi_range": [
            2.0,
            5.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.9,
            "notes": "Must have governance framework before initiating studies"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "kol_engagement",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOL involvement improves study design and enrollment"
          },
          {
            "pillar_id": "publications",
            "dependency_type": "sequential",
            "strength": 0.85,
            "notes": "Evidence generation feeds publication strategy"
          }
        ],
        "enables": [
          "evidence_interpretation",
          "market_access_support",
          "publications"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.1,
            "timeline_multiplier": 1.05,
            "regulatory_complexity_multiplier": 1.15
          },
          "notes": "MHRA and NHS approval requirements; strong emphasis on health economics data"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "timeline_multiplier": 1.2,
            "regulatory_complexity_multiplier": 1.3
          },
          "notes": "FDA requirements most stringent; highest evidence generation costs globally"
        },
        "EU": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "timeline_multiplier": 1.1,
            "regulatory_complexity_multiplier": 1.2
          },
          "notes": "EMA and member state requirements; HTA evidence requirements vary by country"
        },
        "Eastern_Europe": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.75,
            "timeline_multiplier": 0.9,
            "regulatory_complexity_multiplier": 0.85
          },
          "notes": "Lower costs; variable regulatory maturity across countries"
        },
        "LATAM": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "timeline_multiplier": 0.95,
            "regulatory_complexity_multiplier": 0.8
          },
          "notes": "Cost-effective region for trials; regulatory timelines variable"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "timeline_multiplier": 0.85,
            "regulatory_complexity_multiplier": 0.75
          },
          "notes": "Rapidly developing clinical trial infrastructure; growing regulatory sophistication"
        },
        "Middle_East": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.85,
            "timeline_multiplier": 1.0,
            "regulatory_complexity_multiplier": 0.9
          },
          "notes": "Emerging clinical trial landscape; government support for research infrastructure"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_clinical_development",
          "vp_medical_affairs"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "budget_approval_threshold_usd": 100000
        },
        "notes": "Core pillar requiring significant investment and long-term commitment"
      }
    },
    {
      "id": "evidence_interpretation",
      "title": "Evidence Interpretation & Synthesis",
      "description": "Design, execute, and manage clinical and non-clinical studies to generate evidence supporting product value proposition and addressing evidence gaps",
      "tags": [
        "clinical_trials",
        "studies",
        "research",
        "data_generation"
      ],
      "maps_strategy": {
        "strategic_intent": "Translate heterogeneous evidence into decision-grade scientific positioning and actionable insights for stakeholders and internal teams.",
        "scientific_narrative": {
          "core_claim": "Evidence is synthesized into clear, balanced, non-promotional scientific understanding that reduces uncertainty and enables appropriate use.",
          "supporting_messages": [
            "Rigorous study design addressing key clinical and economic questions",
            "Evidence aligned with regulatory, payer, and clinical stakeholder needs",
            "Prospective data generation to complement existing evidence base"
          ],
          "data_of_interest": [
            "Clinical trial data (efficacy, safety, QoL)",
            "Health economics data (cost-effectiveness, budget impact)",
            "Patient-reported outcomes",
            "Biomarker and mechanistic data"
          ],
          "differentiators": [
            "Evidence quality and regulatory grade",
            "Comprehensive endpoints addressing multiple stakeholder needs",
            "Innovative trial designs (adaptive, pragmatic)"
          ],
          "channel_families": [
            "scientific_publications",
            "congress",
            "field_scientific_exchange"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "prelaunch_T-48_to_T-24",
            "perilaunch_T-24_to_T-12",
            "launch_T-12_to_T0",
            "postlaunch_T0_to_T12",
            "beyond_T12"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Focus on pivotal trial design and execution; early evidence generation for regulatory submissions",
            "perilaunch_T-24_to_T-12": "Complete pivotal studies; initiate post-hoc analyses and supplementary studies",
            "launch_T-12_to_T0": "Finalize study reports; prepare for publication and dissemination",
            "postlaunch_T0_to_T12": "Conduct confirmatory studies and address emerging evidence gaps"
          }
        },
        "evidence": {
          "evidence_dependency": "required",
          "evidence_gaps": [
            "Head-to-head comparator data",
            "Long-term safety and efficacy",
            "Special population data (pediatric, elderly, comorbidities)",
            "Cost-effectiveness in target markets"
          ],
          "prioritized_questions": [
            "What clinical endpoints matter most to regulators, payers, and clinicians?",
            "What study designs provide most credible evidence for stakeholder needs?",
            "How can we generate evidence efficiently while maintaining quality?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "medium",
        "base_priority_score": 0.55,
        "priority_distribution": {
          "mean": 0.55,
          "stddev": 0.12,
          "min": 0.31000000000000005,
          "max": 0.79,
          "confidence_level": "medium"
        },
        "dynamic_priority_factors": {
          "evidence_complexity": {
            "weight": 0.3,
            "measurement": "Heterogeneity, endpoints, and comparability challenges across data sources"
          },
          "stakeholder_uncertainty": {
            "weight": 0.25,
            "measurement": "Degree of ambiguity in HCP/payer understanding of evidence"
          },
          "competitive_noise": {
            "weight": 0.2,
            "measurement": "Volume and impact of competitor evidence/messages"
          },
          "internal_alignment_need": {
            "weight": 0.15,
            "measurement": "Cross-functional need for a single scientific narrative"
          },
          "resource_availability": {
            "weight": 0.1,
            "measurement": "Availability of analytics and medical writing capacity"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "insights_synthesis",
          "scientific_platform",
          "evidence_communication",
          "systematic_review_support"
        ],
        "ineligible_tactic_families": [
          "medical_education",
          "digital_omnichannel"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "tier_2",
        "minimum_confidence_required": 0.7,
        "primary_stakeholder_category_keys": [
          "academia_research",
          "external_experts",
          "regulators"
        ],
        "secondary_stakeholder_category_keys": [
          "market_access_payers",
          "data_tech_partners"
        ],
        "cascade_probability_weights": {
          "evidence_generation": 0.95,
          "advisory_boards": 0.75,
          "data_partnership": 0.7
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "Real-time data streaming studies",
              "API-integrated patient registries",
              "Blockchain-verified study protocols",
              "AI-powered patient matching",
              "Decentralized clinical trials"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.3
          },
          "digital_adopter": {
            "tactics": [
              "Electronic data capture (EDC) systems",
              "Virtual study monitoring",
              "Digital consent processes",
              "Hybrid trial designs",
              "Remote patient monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.1
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional CRF with digital backup",
              "Phone-based patient follow-up",
              "Paper-digital hybrid systems",
              "In-person site visits",
              "Conventional monitoring"
            ],
            "applicability_score": 0.6,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "offline_only": {
            "tactics": [
              "Paper-based data collection",
              "Postal patient surveys",
              "In-person interviews only",
              "Traditional statistical analysis",
              "Physical site monitoring"
            ],
            "applicability_score": 0.4,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "FDA-preapproved study protocols",
              "Independent data monitoring committee",
              "Third-party statistical analysis",
              "Full audit trail documentation",
              "GCP-compliant operations"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.4
          },
          "high": {
            "tactics": [
              "IRB-approved protocols",
              "Regular compliance monitoring",
              "Standard audit procedures",
              "Documentation requirements",
              "Quality assurance protocols"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "medium": {
            "tactics": [
              "Standard ethical approval",
              "Routine monitoring",
              "Basic documentation",
              "Standard reporting",
              "Internal QA reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Minimal approval requirements",
              "Self-monitoring protocols",
              "Streamlined documentation",
              "Simplified reporting",
              "Basic oversight"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_data_sensitivity": {
          "very_high": {
            "tactics": [
              "De-identification at source",
              "Encrypted data transmission",
              "Secure multi-party computation",
              "Zero-knowledge proof protocols",
              "Federated learning approaches"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.35
          },
          "high": {
            "tactics": [
              "Pseudonymization protocols",
              "Encrypted databases",
              "Access control systems",
              "Regular security audits",
              "Privacy-preserving analytics"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "high",
            "cost_multiplier": 1.15
          },
          "medium": {
            "tactics": [
              "Standard data protection",
              "Basic encryption",
              "User authentication",
              "Periodic reviews",
              "Standard privacy measures"
            ],
            "applicability_score": 0.65,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Basic anonymization",
              "Standard security",
              "Simple access controls",
              "Minimal restrictions",
              "Standard data handling"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_cross_border": {
          "restricted": {
            "tactics": [
              "Country-specific protocols",
              "Local PI requirements",
              "Regional data centers",
              "Jurisdiction-specific approvals",
              "Local ethics committees"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "unrestricted": {
            "tactics": [
              "Global protocol harmonization",
              "Central data management",
              "Unified approval processes",
              "Cross-border data sharing",
              "International coordination"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 500000,
          "typical": 2000000,
          "max": 10000000
        },
        "resource_requirements": {
          "ftes": {
            "clinical_operations_lead": 0.5,
            "clinical_project_manager": 1.0,
            "clinical_research_associates": 2.0,
            "data_manager": 0.5,
            "medical_monitor": 0.25,
            "biostatistician": 0.3
          },
          "external_vendors": [
            "CRO (clinical research organization)",
            "central_lab",
            "imaging_core_lab",
            "data_management_vendor"
          ]
        },
        "timeline_estimate_months": {
          "min": 12,
          "typical": 24,
          "max": 48
        },
        "roi_metrics": {
          "primary": "evidence_quality_score",
          "secondary": [
            "regulatory_approval_acceleration",
            "payer_coverage_probability",
            "publication_impact_factor"
          ],
          "expected_roi_range": [
            2.0,
            5.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.9,
            "notes": "Must have governance framework before initiating studies"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "kol_engagement",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOL involvement improves study design and enrollment"
          },
          {
            "pillar_id": "publications",
            "dependency_type": "sequential",
            "strength": 0.85,
            "notes": "Evidence generation feeds publication strategy"
          }
        ],
        "enables": [
          "evidence_interpretation",
          "market_access_support",
          "publications"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.1,
            "timeline_multiplier": 1.05,
            "regulatory_complexity_multiplier": 1.15
          },
          "notes": "MHRA and NHS approval requirements; strong emphasis on health economics data"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "timeline_multiplier": 1.2,
            "regulatory_complexity_multiplier": 1.3
          },
          "notes": "FDA requirements most stringent; highest evidence generation costs globally"
        },
        "EU": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "timeline_multiplier": 1.1,
            "regulatory_complexity_multiplier": 1.2
          },
          "notes": "EMA and member state requirements; HTA evidence requirements vary by country"
        },
        "Eastern_Europe": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.75,
            "timeline_multiplier": 0.9,
            "regulatory_complexity_multiplier": 0.85
          },
          "notes": "Lower costs; variable regulatory maturity across countries"
        },
        "LATAM": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "timeline_multiplier": 0.95,
            "regulatory_complexity_multiplier": 0.8
          },
          "notes": "Cost-effective region for trials; regulatory timelines variable"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "timeline_multiplier": 0.85,
            "regulatory_complexity_multiplier": 0.75
          },
          "notes": "Rapidly developing clinical trial infrastructure; growing regulatory sophistication"
        },
        "Middle_East": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.85,
            "timeline_multiplier": 1.0,
            "regulatory_complexity_multiplier": 0.9
          },
          "notes": "Emerging clinical trial landscape; government support for research infrastructure"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_medical_affairs",
          "medical_strategy_lead"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "budget_approval_threshold_usd": 100000
        },
        "notes": "Core pillar requiring significant investment and long-term commitment"
      }
    },
    {
      "id": "scientific_exchange",
      "title": "Scientific Exchange",
      "description": "Design, execute, and manage clinical and non-clinical studies to generate evidence supporting product value proposition and addressing evidence gaps",
      "tags": [
        "clinical_trials",
        "studies",
        "research",
        "data_generation"
      ],
      "maps_strategy": {
        "strategic_intent": "Enable compliant, non-promotional scientific dialogue that advances understanding of disease, MOA, and evidence across priority stakeholders.",
        "scientific_narrative": {
          "core_claim": "Scientific exchange is unbiased, evidence-based, and tailored to stakeholder needs while respecting local codes and governance.",
          "supporting_messages": [
            "Rigorous study design addressing key clinical and economic questions",
            "Evidence aligned with regulatory, payer, and clinical stakeholder needs",
            "Prospective data generation to complement existing evidence base"
          ],
          "data_of_interest": [
            "Clinical trial data (efficacy, safety, QoL)",
            "Health economics data (cost-effectiveness, budget impact)",
            "Patient-reported outcomes",
            "Biomarker and mechanistic data"
          ],
          "differentiators": [
            "Evidence quality and regulatory grade",
            "Comprehensive endpoints addressing multiple stakeholder needs",
            "Innovative trial designs (adaptive, pragmatic)"
          ],
          "channel_families": [
            "scientific_publications",
            "congress",
            "field_scientific_exchange"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "perilaunch_T-24_to_T-12",
            "launch_T-12_to_T0",
            "postlaunch_T0_to_T12",
            "beyond_T12"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Focus on pivotal trial design and execution; early evidence generation for regulatory submissions",
            "perilaunch_T-24_to_T-12": "Complete pivotal studies; initiate post-hoc analyses and supplementary studies",
            "launch_T-12_to_T0": "Finalize study reports; prepare for publication and dissemination",
            "postlaunch_T0_to_T12": "Conduct confirmatory studies and address emerging evidence gaps"
          }
        },
        "evidence": {
          "evidence_dependency": "required",
          "evidence_gaps": [
            "Head-to-head comparator data",
            "Long-term safety and efficacy",
            "Special population data (pediatric, elderly, comorbidities)",
            "Cost-effectiveness in target markets"
          ],
          "prioritized_questions": [
            "What clinical endpoints matter most to regulators, payers, and clinicians?",
            "What study designs provide most credible evidence for stakeholder needs?",
            "How can we generate evidence efficiently while maintaining quality?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "high",
        "base_priority_score": 0.75,
        "priority_distribution": {
          "mean": 0.75,
          "stddev": 0.1,
          "min": 0.55,
          "max": 0.95,
          "confidence_level": "high"
        },
        "dynamic_priority_factors": {
          "stakeholder_access": {
            "weight": 0.3,
            "measurement": "Feasibility of access to priority HCPs/KOLs and decision-makers"
          },
          "unmet_scientific_questions": {
            "weight": 0.25,
            "measurement": "Volume and importance of unanswered questions in field interactions"
          },
          "compliance_risk": {
            "weight": 0.2,
            "measurement": "Local code restrictions and engagement risk"
          },
          "launch_timing": {
            "weight": 0.15,
            "measurement": "Time sensitivity relative to key lifecycle milestones"
          },
          "field_capacity": {
            "weight": 0.1,
            "measurement": "MSL bandwidth and coverage"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "msl_scientific_dialogue",
          "scientific_response",
          "advisory_boards",
          "medical_information_enablement"
        ],
        "ineligible_tactic_families": [
          "medical_education",
          "digital_omnichannel"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "tier_2",
        "minimum_confidence_required": 0.75,
        "primary_stakeholder_category_keys": [
          "academia_research",
          "external_experts",
          "regulators"
        ],
        "secondary_stakeholder_category_keys": [
          "market_access_payers",
          "data_tech_partners"
        ],
        "cascade_probability_weights": {
          "evidence_generation": 0.95,
          "advisory_boards": 0.75,
          "data_partnership": 0.7
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "Real-time data streaming studies",
              "API-integrated patient registries",
              "Blockchain-verified study protocols",
              "AI-powered patient matching",
              "Decentralized clinical trials"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.3
          },
          "digital_adopter": {
            "tactics": [
              "Electronic data capture (EDC) systems",
              "Virtual study monitoring",
              "Digital consent processes",
              "Hybrid trial designs",
              "Remote patient monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.1
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional CRF with digital backup",
              "Phone-based patient follow-up",
              "Paper-digital hybrid systems",
              "In-person site visits",
              "Conventional monitoring"
            ],
            "applicability_score": 0.6,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "offline_only": {
            "tactics": [
              "Paper-based data collection",
              "Postal patient surveys",
              "In-person interviews only",
              "Traditional statistical analysis",
              "Physical site monitoring"
            ],
            "applicability_score": 0.4,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "FDA-preapproved study protocols",
              "Independent data monitoring committee",
              "Third-party statistical analysis",
              "Full audit trail documentation",
              "GCP-compliant operations"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.4
          },
          "high": {
            "tactics": [
              "IRB-approved protocols",
              "Regular compliance monitoring",
              "Standard audit procedures",
              "Documentation requirements",
              "Quality assurance protocols"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "medium": {
            "tactics": [
              "Standard ethical approval",
              "Routine monitoring",
              "Basic documentation",
              "Standard reporting",
              "Internal QA reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Minimal approval requirements",
              "Self-monitoring protocols",
              "Streamlined documentation",
              "Simplified reporting",
              "Basic oversight"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_data_sensitivity": {
          "very_high": {
            "tactics": [
              "De-identification at source",
              "Encrypted data transmission",
              "Secure multi-party computation",
              "Zero-knowledge proof protocols",
              "Federated learning approaches"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.35
          },
          "high": {
            "tactics": [
              "Pseudonymization protocols",
              "Encrypted databases",
              "Access control systems",
              "Regular security audits",
              "Privacy-preserving analytics"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "high",
            "cost_multiplier": 1.15
          },
          "medium": {
            "tactics": [
              "Standard data protection",
              "Basic encryption",
              "User authentication",
              "Periodic reviews",
              "Standard privacy measures"
            ],
            "applicability_score": 0.65,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Basic anonymization",
              "Standard security",
              "Simple access controls",
              "Minimal restrictions",
              "Standard data handling"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_cross_border": {
          "restricted": {
            "tactics": [
              "Country-specific protocols",
              "Local PI requirements",
              "Regional data centers",
              "Jurisdiction-specific approvals",
              "Local ethics committees"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "unrestricted": {
            "tactics": [
              "Global protocol harmonization",
              "Central data management",
              "Unified approval processes",
              "Cross-border data sharing",
              "International coordination"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 500000,
          "typical": 2000000,
          "max": 10000000
        },
        "resource_requirements": {
          "ftes": {
            "clinical_operations_lead": 0.5,
            "clinical_project_manager": 1.0,
            "clinical_research_associates": 2.0,
            "data_manager": 0.5,
            "medical_monitor": 0.25,
            "biostatistician": 0.3
          },
          "external_vendors": [
            "CRO (clinical research organization)",
            "central_lab",
            "imaging_core_lab",
            "data_management_vendor"
          ]
        },
        "timeline_estimate_months": {
          "min": 12,
          "typical": 24,
          "max": 48
        },
        "roi_metrics": {
          "primary": "evidence_quality_score",
          "secondary": [
            "regulatory_approval_acceleration",
            "payer_coverage_probability",
            "publication_impact_factor"
          ],
          "expected_roi_range": [
            2.0,
            5.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.9,
            "notes": "Must have governance framework before initiating studies"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "kol_engagement",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOL involvement improves study design and enrollment"
          },
          {
            "pillar_id": "publications",
            "dependency_type": "sequential",
            "strength": 0.85,
            "notes": "Evidence generation feeds publication strategy"
          }
        ],
        "enables": [
          "evidence_interpretation",
          "market_access_support",
          "publications"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.1,
            "timeline_multiplier": 1.05,
            "regulatory_complexity_multiplier": 1.15
          },
          "notes": "MHRA and NHS approval requirements; strong emphasis on health economics data"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "timeline_multiplier": 1.2,
            "regulatory_complexity_multiplier": 1.3
          },
          "notes": "FDA requirements most stringent; highest evidence generation costs globally"
        },
        "EU": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "timeline_multiplier": 1.1,
            "regulatory_complexity_multiplier": 1.2
          },
          "notes": "EMA and member state requirements; HTA evidence requirements vary by country"
        },
        "Eastern_Europe": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.75,
            "timeline_multiplier": 0.9,
            "regulatory_complexity_multiplier": 0.85
          },
          "notes": "Lower costs; variable regulatory maturity across countries"
        },
        "LATAM": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "timeline_multiplier": 0.95,
            "regulatory_complexity_multiplier": 0.8
          },
          "notes": "Cost-effective region for trials; regulatory timelines variable"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "timeline_multiplier": 0.85,
            "regulatory_complexity_multiplier": 0.75
          },
          "notes": "Rapidly developing clinical trial infrastructure; growing regulatory sophistication"
        },
        "Middle_East": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.85,
            "timeline_multiplier": 1.0,
            "regulatory_complexity_multiplier": 0.9
          },
          "notes": "Emerging clinical trial landscape; government support for research infrastructure"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_medical_affairs",
          "medical_strategy_lead",
          "field_medical_lead"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "budget_approval_threshold_usd": 100000
        },
        "notes": "Core pillar requiring significant investment and long-term commitment"
      }
    },
    {
      "id": "publications",
      "title": "Scientific Publications",
      "description": "Design, execute, and manage clinical and non-clinical studies to generate evidence supporting product value proposition and addressing evidence gaps",
      "tags": [
        "clinical_trials",
        "studies",
        "research",
        "data_generation"
      ],
      "maps_strategy": {
        "strategic_intent": "Plan, develop, and disseminate scientific publications that address evidence gaps and support credible medical understanding over the lifecycle.",
        "scientific_narrative": {
          "core_claim": "Peer-reviewed communication of evidence builds durable scientific credibility and improves interpretability of the totality of data.",
          "supporting_messages": [
            "Rigorous study design addressing key clinical and economic questions",
            "Evidence aligned with regulatory, payer, and clinical stakeholder needs",
            "Prospective data generation to complement existing evidence base"
          ],
          "data_of_interest": [
            "Clinical trial data (efficacy, safety, QoL)",
            "Health economics data (cost-effectiveness, budget impact)",
            "Patient-reported outcomes",
            "Biomarker and mechanistic data"
          ],
          "differentiators": [
            "Evidence quality and regulatory grade",
            "Comprehensive endpoints addressing multiple stakeholder needs",
            "Innovative trial designs (adaptive, pragmatic)"
          ],
          "channel_families": [
            "scientific_publications",
            "congress",
            "field_scientific_exchange"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "prelaunch_T-48_to_T-24",
            "perilaunch_T-24_to_T-12",
            "launch_T-12_to_T0",
            "postlaunch_T0_to_T12"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Focus on pivotal trial design and execution; early evidence generation for regulatory submissions",
            "perilaunch_T-24_to_T-12": "Complete pivotal studies; initiate post-hoc analyses and supplementary studies",
            "launch_T-12_to_T0": "Finalize study reports; prepare for publication and dissemination",
            "postlaunch_T0_to_T12": "Conduct confirmatory studies and address emerging evidence gaps"
          }
        },
        "evidence": {
          "evidence_dependency": "required",
          "evidence_gaps": [
            "Head-to-head comparator data",
            "Long-term safety and efficacy",
            "Special population data (pediatric, elderly, comorbidities)",
            "Cost-effectiveness in target markets"
          ],
          "prioritized_questions": [
            "What clinical endpoints matter most to regulators, payers, and clinicians?",
            "What study designs provide most credible evidence for stakeholder needs?",
            "How can we generate evidence efficiently while maintaining quality?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "high",
        "base_priority_score": 0.75,
        "priority_distribution": {
          "mean": 0.75,
          "stddev": 0.1,
          "min": 0.55,
          "max": 0.95,
          "confidence_level": "high"
        },
        "dynamic_priority_factors": {
          "publication_gap_severity": {
            "weight": 0.3,
            "measurement": "Magnitude of publication gaps vs stakeholder needs"
          },
          "journal_congress_fit": {
            "weight": 0.2,
            "measurement": "Alignment of target venues with priority audiences"
          },
          "data_readiness": {
            "weight": 0.25,
            "measurement": "Availability and maturity of datasets for publication"
          },
          "competitive_publications": {
            "weight": 0.15,
            "measurement": "Competitor publication cadence and impact"
          },
          "operational_feasibility": {
            "weight": 0.1,
            "measurement": "Author availability and publication operations readiness"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "publication_strategy",
          "manuscript_development",
          "congress_abstracts",
          "publication_gap_analysis"
        ],
        "ineligible_tactic_families": [
          "medical_education",
          "digital_omnichannel"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "tier_2",
        "minimum_confidence_required": 0.75,
        "primary_stakeholder_category_keys": [
          "academia_research",
          "external_experts",
          "regulators"
        ],
        "secondary_stakeholder_category_keys": [
          "market_access_payers",
          "data_tech_partners"
        ],
        "cascade_probability_weights": {
          "evidence_generation": 0.95,
          "advisory_boards": 0.75,
          "data_partnership": 0.7
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "Real-time data streaming studies",
              "API-integrated patient registries",
              "Blockchain-verified study protocols",
              "AI-powered patient matching",
              "Decentralized clinical trials"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.3
          },
          "digital_adopter": {
            "tactics": [
              "Electronic data capture (EDC) systems",
              "Virtual study monitoring",
              "Digital consent processes",
              "Hybrid trial designs",
              "Remote patient monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.1
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional CRF with digital backup",
              "Phone-based patient follow-up",
              "Paper-digital hybrid systems",
              "In-person site visits",
              "Conventional monitoring"
            ],
            "applicability_score": 0.6,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "offline_only": {
            "tactics": [
              "Paper-based data collection",
              "Postal patient surveys",
              "In-person interviews only",
              "Traditional statistical analysis",
              "Physical site monitoring"
            ],
            "applicability_score": 0.4,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "FDA-preapproved study protocols",
              "Independent data monitoring committee",
              "Third-party statistical analysis",
              "Full audit trail documentation",
              "GCP-compliant operations"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.4
          },
          "high": {
            "tactics": [
              "IRB-approved protocols",
              "Regular compliance monitoring",
              "Standard audit procedures",
              "Documentation requirements",
              "Quality assurance protocols"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "medium": {
            "tactics": [
              "Standard ethical approval",
              "Routine monitoring",
              "Basic documentation",
              "Standard reporting",
              "Internal QA reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Minimal approval requirements",
              "Self-monitoring protocols",
              "Streamlined documentation",
              "Simplified reporting",
              "Basic oversight"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_data_sensitivity": {
          "very_high": {
            "tactics": [
              "De-identification at source",
              "Encrypted data transmission",
              "Secure multi-party computation",
              "Zero-knowledge proof protocols",
              "Federated learning approaches"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.35
          },
          "high": {
            "tactics": [
              "Pseudonymization protocols",
              "Encrypted databases",
              "Access control systems",
              "Regular security audits",
              "Privacy-preserving analytics"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "high",
            "cost_multiplier": 1.15
          },
          "medium": {
            "tactics": [
              "Standard data protection",
              "Basic encryption",
              "User authentication",
              "Periodic reviews",
              "Standard privacy measures"
            ],
            "applicability_score": 0.65,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Basic anonymization",
              "Standard security",
              "Simple access controls",
              "Minimal restrictions",
              "Standard data handling"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_cross_border": {
          "restricted": {
            "tactics": [
              "Country-specific protocols",
              "Local PI requirements",
              "Regional data centers",
              "Jurisdiction-specific approvals",
              "Local ethics committees"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "unrestricted": {
            "tactics": [
              "Global protocol harmonization",
              "Central data management",
              "Unified approval processes",
              "Cross-border data sharing",
              "International coordination"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 500000,
          "typical": 2000000,
          "max": 10000000
        },
        "resource_requirements": {
          "ftes": {
            "clinical_operations_lead": 0.5,
            "clinical_project_manager": 1.0,
            "clinical_research_associates": 2.0,
            "data_manager": 0.5,
            "medical_monitor": 0.25,
            "biostatistician": 0.3
          },
          "external_vendors": [
            "CRO (clinical research organization)",
            "central_lab",
            "imaging_core_lab",
            "data_management_vendor"
          ]
        },
        "timeline_estimate_months": {
          "min": 12,
          "typical": 24,
          "max": 48
        },
        "roi_metrics": {
          "primary": "evidence_quality_score",
          "secondary": [
            "regulatory_approval_acceleration",
            "payer_coverage_probability",
            "publication_impact_factor"
          ],
          "expected_roi_range": [
            2.0,
            5.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.9,
            "notes": "Must have governance framework before initiating studies"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "kol_engagement",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOL involvement improves study design and enrollment"
          },
          {
            "pillar_id": "publications",
            "dependency_type": "sequential",
            "strength": 0.85,
            "notes": "Evidence generation feeds publication strategy"
          }
        ],
        "enables": [
          "evidence_interpretation",
          "market_access_support",
          "publications"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.1,
            "timeline_multiplier": 1.05,
            "regulatory_complexity_multiplier": 1.15
          },
          "notes": "MHRA and NHS approval requirements; strong emphasis on health economics data"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "timeline_multiplier": 1.2,
            "regulatory_complexity_multiplier": 1.3
          },
          "notes": "FDA requirements most stringent; highest evidence generation costs globally"
        },
        "EU": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "timeline_multiplier": 1.1,
            "regulatory_complexity_multiplier": 1.2
          },
          "notes": "EMA and member state requirements; HTA evidence requirements vary by country"
        },
        "Eastern_Europe": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.75,
            "timeline_multiplier": 0.9,
            "regulatory_complexity_multiplier": 0.85
          },
          "notes": "Lower costs; variable regulatory maturity across countries"
        },
        "LATAM": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "timeline_multiplier": 0.95,
            "regulatory_complexity_multiplier": 0.8
          },
          "notes": "Cost-effective region for trials; regulatory timelines variable"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "timeline_multiplier": 0.85,
            "regulatory_complexity_multiplier": 0.75
          },
          "notes": "Rapidly developing clinical trial infrastructure; growing regulatory sophistication"
        },
        "Middle_East": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.85,
            "timeline_multiplier": 1.0,
            "regulatory_complexity_multiplier": 0.9
          },
          "notes": "Emerging clinical trial landscape; government support for research infrastructure"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_medical_affairs",
          "medical_strategy_lead",
          "publications_lead"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "budget_approval_threshold_usd": 100000
        },
        "notes": "Core pillar requiring significant investment and long-term commitment"
      }
    },
    {
      "id": "kol_engagement",
      "title": "KOL Engagement & Advocacy",
      "description": "Identify, engage, and develop relationships with key opinion leaders to build scientific advocacy and influence clinical practice",
      "tags": [
        "kol",
        "thought_leaders",
        "advocacy",
        "influence"
      ],
      "maps_strategy": {
        "strategic_intent": "Build network of influential thought leaders who understand, support, and advocate for product value proposition to drive clinical adoption and shape treatment paradigms",
        "scientific_narrative": {
          "core_claim": "Strategic KOL partnerships drive scientific credibility, clinical adoption, and treatment landscape evolution",
          "supporting_messages": [
            "KOLs validate scientific rigor and clinical relevance",
            "Thought leader advocacy accelerates practice change",
            "Expert networks amplify evidence dissemination"
          ],
          "data_of_interest": [
            "KOL publication history and influence metrics",
            "Opinion leader treatment preferences and prescribing patterns",
            "Guideline committee participation and voting patterns",
            "Conference speaking and presentation history"
          ],
          "differentiators": [
            "Strategic relationship depth and quality",
            "KOL alignment with product value proposition",
            "Network effect and influence cascade"
          ],
          "channel_families": [
            "field_scientific_exchange",
            "congress",
            "scientific_publications"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "prelaunch_T-48_to_T-24",
            "perilaunch_T-24_to_T-12",
            "launch_T-12_to_T0",
            "postlaunch_T0_to_T12"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Identify and establish relationships with tier 1 KOLs; engage in study design and protocol development",
            "perilaunch_T-24_to_T-12": "Deepen engagement; involve in data interpretation and publication planning",
            "launch_T-12_to_T0": "Activate advocacy; speaker programs, advisory boards, launch activities",
            "postlaunch_T0_to_T12": "Sustain advocacy; real-world evidence collaboration, guideline influence"
          }
        },
        "evidence": {
          "evidence_dependency": "supportive",
          "evidence_gaps": [
            "KOL perception and sentiment data",
            "Influence network mapping",
            "Advocacy impact measurement"
          ],
          "prioritized_questions": [
            "Who are the most influential KOLs in target therapeutic area?",
            "What drives KOL advocacy and support?",
            "How do we measure KOL engagement effectiveness?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "very_high",
        "base_priority_score": 0.85,
        "priority_distribution": {
          "mean": 0.85,
          "stddev": 0.08,
          "min": 0.7,
          "max": 0.98,
          "confidence_level": "high"
        },
        "dynamic_priority_factors": {
          "competitive_advocacy_gap": {
            "weight": 0.35,
            "measurement": "Competitor KOL advocacy advantage"
          },
          "guideline_influence_opportunity": {
            "weight": 0.25,
            "measurement": "Upcoming guideline updates and KOL committee participation"
          },
          "launch_proximity": {
            "weight": 0.2,
            "measurement": "Time to launch (higher priority closer to launch)"
          },
          "kol_availability": {
            "weight": 0.15,
            "measurement": "Target KOL accessibility and engagement capacity"
          },
          "budget_availability": {
            "weight": 0.05,
            "measurement": "Resource allocation for KOL programs"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "scientific_exchange",
          "advisory_boards",
          "publication_strategy",
          "evidence_dissemination",
          "medical_education"
        ],
        "ineligible_tactic_families": [
          "internal_enablement",
          "data_partnership"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "output",
        "minimum_confidence_required": "medium",
        "primary_stakeholder_category_keys": [
          "external_experts"
        ],
        "secondary_stakeholder_category_keys": [
          "healthcare_professionals",
          "academia_research",
          "societies_associations"
        ],
        "cascade_probability_weights": {
          "scientific_exchange": 0.95,
          "advisory_boards": 0.9,
          "publication_strategy": 0.85
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "AI-powered KOL identification and mapping",
              "Real-time social media monitoring and engagement",
              "Virtual advisory boards with interactive features",
              "Digital influence analytics dashboards",
              "Automated sentiment analysis"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "digital_adopter": {
            "tactics": [
              "Hybrid advisory boards",
              "Video conference engagements",
              "Digital speaker programs",
              "Online KOL portals",
              "Virtual congress participation"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional advisory boards",
              "In-person speaker programs",
              "Face-to-face MSL meetings",
              "Phone-based follow-ups",
              "Email engagement"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          },
          "offline_only": {
            "tactics": [
              "In-person only meetings",
              "Traditional congress networking",
              "Physical speaker programs",
              "Mail-based communications",
              "One-on-one in-person engagements"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "low",
            "cost_multiplier": 1.1
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "Fully disclosed interactions with transparency reporting",
              "Independent facilitator for advisory boards",
              "Fair market value (FMV) validation for all payments",
              "Legal review of all engagement materials",
              "Comprehensive documentation and audit trails"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "high": {
            "tactics": [
              "Standard disclosure protocols",
              "FMV-based compensation",
              "MLR review of materials",
              "Standard documentation",
              "Compliance monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.25
          },
          "medium": {
            "tactics": [
              "Basic disclosure requirements",
              "Market-rate compensation",
              "Standard approval processes",
              "Routine documentation",
              "Periodic compliance reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.1
          },
          "low": {
            "tactics": [
              "Minimal disclosure requirements",
              "Flexible compensation models",
              "Streamlined approval processes",
              "Basic documentation",
              "Self-monitoring"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_stakeholder_influence": {
          "tier_1_national_leaders": {
            "tactics": [
              "Strategic advisory board membership",
              "Publication steering committee roles",
              "Paid speaker bureau (top tier)",
              "Research collaboration opportunities",
              "Guideline committee engagement support"
            ],
            "applicability_score": 0.95,
            "engagement_frequency": "quarterly",
            "typical_honorarium_usd": 5000
          },
          "tier_2_regional_leaders": {
            "tactics": [
              "Advisory board participation",
              "Speaker program faculty",
              "Publication co-authorship",
              "Local congress participation",
              "Regional advocacy activities"
            ],
            "applicability_score": 0.85,
            "engagement_frequency": "bi-annually",
            "typical_honorarium_usd": 2500
          },
          "tier_3_emerging_experts": {
            "tactics": [
              "Early career advisory panels",
              "Poster presentations support",
              "Young investigator programs",
              "Mentorship opportunities",
              "Network building activities"
            ],
            "applicability_score": 0.7,
            "engagement_frequency": "annually",
            "typical_honorarium_usd": 1000
          }
        },
        "by_engagement_complexity": {
          "very_complex": {
            "tactics": [
              "Multi-stakeholder strategic advisory councils",
              "Cross-functional scientific steering committees",
              "International coordinating committees",
              "Long-term collaborative research partnerships"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.6
          },
          "complex": {
            "tactics": [
              "Disease state advisory boards",
              "Product-specific advisory meetings",
              "Publication planning committees",
              "Speaker faculty development programs"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "high",
            "cost_multiplier": 1.3
          },
          "moderate": {
            "tactics": [
              "One-on-one MSL engagements",
              "Small group dinner meetings",
              "Congress booth interactions",
              "Structured scientific dialogues"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.1
          },
          "simple": {
            "tactics": [
              "Email updates and information sharing",
              "Phone-based scientific exchanges",
              "Virtual coffee chats",
              "Literature sharing"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 200000,
          "typical": 1000000,
          "max": 5000000
        },
        "resource_requirements": {
          "ftes": {
            "kol_management_lead": 0.5,
            "msl_team": 5.0,
            "speaker_bureau_coordinator": 0.25,
            "advisory_board_manager": 0.5
          },
          "external_vendors": [
            "speaker_bureau_management",
            "advisory_board_logistics",
            "kol_mapping_analytics_provider"
          ]
        },
        "timeline_estimate_months": {
          "relationship_building": 6,
          "advocacy_activation": 12,
          "sustained_engagement": "ongoing"
        },
        "roi_metrics": {
          "primary": "kol_advocacy_index",
          "secondary": [
            "prescriber_influence_score",
            "publication_impact",
            "guideline_citation_rate",
            "congress_speaking_engagements"
          ],
          "expected_roi_range": [
            3.0,
            8.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.95,
            "notes": "Compliance framework essential for KOL engagement activities"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "publications",
            "dependency_type": "synergistic",
            "strength": 0.9,
            "notes": "KOL engagement drives publication strategy and authorship"
          },
          {
            "pillar_id": "scientific_exchange",
            "dependency_type": "synergistic",
            "strength": 0.85,
            "notes": "KOL relationships enhance field medical activities"
          },
          {
            "pillar_id": "evidence_generation",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOLs contribute to study design and patient recruitment"
          }
        ],
        "enables": [
          "hcp_education",
          "scientific_exchange",
          "congress_presence"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "engagement_complexity_multiplier": 1.2,
            "compliance_risk_multiplier": 1.25
          },
          "notes": "ABPI code compliance critical; high transparency requirements"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "engagement_complexity_multiplier": 1.3,
            "compliance_risk_multiplier": 1.5
          },
          "notes": "Sunshine Act reporting mandatory; highest compliance burden globally"
        },
        "EU": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.2,
            "engagement_complexity_multiplier": 1.15,
            "compliance_risk_multiplier": 1.2
          },
          "notes": "EFPIA disclosure requirements; member state variability"
        },
        "Eastern_Europe": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "engagement_complexity_multiplier": 0.85,
            "compliance_risk_multiplier": 0.75
          },
          "notes": "Lower engagement costs; emerging KOL networks"
        },
        "LATAM": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.55,
            "engagement_complexity_multiplier": 0.9,
            "compliance_risk_multiplier": 0.7
          },
          "notes": "Relationship-driven engagement; variable compliance frameworks"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.5,
            "engagement_complexity_multiplier": 0.8,
            "compliance_risk_multiplier": 0.65
          },
          "notes": "Growing KOL landscape; digital engagement opportunities"
        },
        "Middle_East": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "engagement_complexity_multiplier": 1.0,
            "compliance_risk_multiplier": 0.8
          },
          "notes": "High-influence KOLs with regional reach; relationship-based culture"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_medical_affairs",
          "kol_management_lead"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "compliance_review_required": true,
          "budget_approval_threshold_usd": 25000
        },
        "notes": "High-risk, high-value pillar requiring rigorous compliance oversight"
      }
    },
    {
      "id": "hcp_education",
      "title": "HCP Education",
      "description": "Design, execute, and manage clinical and non-clinical studies to generate evidence supporting product value proposition and addressing evidence gaps",
      "tags": [
        "clinical_trials",
        "studies",
        "research",
        "data_generation"
      ],
      "maps_strategy": {
        "strategic_intent": "Improve HCP capability and confidence through compliant education addressing clinical practice gaps and appropriate evidence interpretation.",
        "scientific_narrative": {
          "core_claim": "Education addresses validated clinical gaps and supports better patient outcomes without promotional framing.",
          "supporting_messages": [
            "Rigorous study design addressing key clinical and economic questions",
            "Evidence aligned with regulatory, payer, and clinical stakeholder needs",
            "Prospective data generation to complement existing evidence base"
          ],
          "data_of_interest": [
            "Clinical trial data (efficacy, safety, QoL)",
            "Health economics data (cost-effectiveness, budget impact)",
            "Patient-reported outcomes",
            "Biomarker and mechanistic data"
          ],
          "differentiators": [
            "Evidence quality and regulatory grade",
            "Comprehensive endpoints addressing multiple stakeholder needs",
            "Innovative trial designs (adaptive, pragmatic)"
          ],
          "channel_families": [
            "scientific_publications",
            "congress",
            "field_scientific_exchange"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "launch_T-12_to_T0",
            "postlaunch_T0_to_T12",
            "beyond_T12"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Focus on pivotal trial design and execution; early evidence generation for regulatory submissions",
            "perilaunch_T-24_to_T-12": "Complete pivotal studies; initiate post-hoc analyses and supplementary studies",
            "launch_T-12_to_T0": "Finalize study reports; prepare for publication and dissemination",
            "postlaunch_T0_to_T12": "Conduct confirmatory studies and address emerging evidence gaps"
          }
        },
        "evidence": {
          "evidence_dependency": "required",
          "evidence_gaps": [
            "Head-to-head comparator data",
            "Long-term safety and efficacy",
            "Special population data (pediatric, elderly, comorbidities)",
            "Cost-effectiveness in target markets"
          ],
          "prioritized_questions": [
            "What clinical endpoints matter most to regulators, payers, and clinicians?",
            "What study designs provide most credible evidence for stakeholder needs?",
            "How can we generate evidence efficiently while maintaining quality?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "high",
        "base_priority_score": 0.75,
        "priority_distribution": {
          "mean": 0.75,
          "stddev": 0.1,
          "min": 0.55,
          "max": 0.95,
          "confidence_level": "high"
        },
        "dynamic_priority_factors": {
          "practice_gap_magnitude": {
            "weight": 0.35,
            "measurement": "Validated practice gaps and their clinical impact"
          },
          "audience_readiness": {
            "weight": 0.2,
            "measurement": "Baseline awareness/competence and willingness to change"
          },
          "channel_fit": {
            "weight": 0.15,
            "measurement": "Suitability of formats and channels to reach HCPs"
          },
          "compliance_constraints": {
            "weight": 0.2,
            "measurement": "Local restrictions on educational support"
          },
          "execution_capacity": {
            "weight": 0.1,
            "measurement": "Medical education ops capacity and partners"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "hcp_education_programs",
          "peer_to_peer_education",
          "clinical_pathway_support",
          "cme_enablement"
        ],
        "ineligible_tactic_families": [
          "medical_education",
          "digital_omnichannel"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "tier_1",
        "minimum_confidence_required": 0.7,
        "primary_stakeholder_category_keys": [
          "academia_research",
          "external_experts",
          "regulators"
        ],
        "secondary_stakeholder_category_keys": [
          "market_access_payers",
          "data_tech_partners"
        ],
        "cascade_probability_weights": {
          "evidence_generation": 0.95,
          "advisory_boards": 0.75,
          "data_partnership": 0.7
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "Real-time data streaming studies",
              "API-integrated patient registries",
              "Blockchain-verified study protocols",
              "AI-powered patient matching",
              "Decentralized clinical trials"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.3
          },
          "digital_adopter": {
            "tactics": [
              "Electronic data capture (EDC) systems",
              "Virtual study monitoring",
              "Digital consent processes",
              "Hybrid trial designs",
              "Remote patient monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.1
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional CRF with digital backup",
              "Phone-based patient follow-up",
              "Paper-digital hybrid systems",
              "In-person site visits",
              "Conventional monitoring"
            ],
            "applicability_score": 0.6,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "offline_only": {
            "tactics": [
              "Paper-based data collection",
              "Postal patient surveys",
              "In-person interviews only",
              "Traditional statistical analysis",
              "Physical site monitoring"
            ],
            "applicability_score": 0.4,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "FDA-preapproved study protocols",
              "Independent data monitoring committee",
              "Third-party statistical analysis",
              "Full audit trail documentation",
              "GCP-compliant operations"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.4
          },
          "high": {
            "tactics": [
              "IRB-approved protocols",
              "Regular compliance monitoring",
              "Standard audit procedures",
              "Documentation requirements",
              "Quality assurance protocols"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "medium": {
            "tactics": [
              "Standard ethical approval",
              "Routine monitoring",
              "Basic documentation",
              "Standard reporting",
              "Internal QA reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Minimal approval requirements",
              "Self-monitoring protocols",
              "Streamlined documentation",
              "Simplified reporting",
              "Basic oversight"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_data_sensitivity": {
          "very_high": {
            "tactics": [
              "De-identification at source",
              "Encrypted data transmission",
              "Secure multi-party computation",
              "Zero-knowledge proof protocols",
              "Federated learning approaches"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.35
          },
          "high": {
            "tactics": [
              "Pseudonymization protocols",
              "Encrypted databases",
              "Access control systems",
              "Regular security audits",
              "Privacy-preserving analytics"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "high",
            "cost_multiplier": 1.15
          },
          "medium": {
            "tactics": [
              "Standard data protection",
              "Basic encryption",
              "User authentication",
              "Periodic reviews",
              "Standard privacy measures"
            ],
            "applicability_score": 0.65,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Basic anonymization",
              "Standard security",
              "Simple access controls",
              "Minimal restrictions",
              "Standard data handling"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_cross_border": {
          "restricted": {
            "tactics": [
              "Country-specific protocols",
              "Local PI requirements",
              "Regional data centers",
              "Jurisdiction-specific approvals",
              "Local ethics committees"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "unrestricted": {
            "tactics": [
              "Global protocol harmonization",
              "Central data management",
              "Unified approval processes",
              "Cross-border data sharing",
              "International coordination"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 500000,
          "typical": 2000000,
          "max": 10000000
        },
        "resource_requirements": {
          "ftes": {
            "clinical_operations_lead": 0.5,
            "clinical_project_manager": 1.0,
            "clinical_research_associates": 2.0,
            "data_manager": 0.5,
            "medical_monitor": 0.25,
            "biostatistician": 0.3
          },
          "external_vendors": [
            "CRO (clinical research organization)",
            "central_lab",
            "imaging_core_lab",
            "data_management_vendor"
          ]
        },
        "timeline_estimate_months": {
          "min": 12,
          "typical": 24,
          "max": 48
        },
        "roi_metrics": {
          "primary": "evidence_quality_score",
          "secondary": [
            "regulatory_approval_acceleration",
            "payer_coverage_probability",
            "publication_impact_factor"
          ],
          "expected_roi_range": [
            2.0,
            5.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.9,
            "notes": "Must have governance framework before initiating studies"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "kol_engagement",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOL involvement improves study design and enrollment"
          },
          {
            "pillar_id": "publications",
            "dependency_type": "sequential",
            "strength": 0.85,
            "notes": "Evidence generation feeds publication strategy"
          }
        ],
        "enables": [
          "evidence_interpretation",
          "market_access_support",
          "publications"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.1,
            "timeline_multiplier": 1.05,
            "regulatory_complexity_multiplier": 1.15
          },
          "notes": "MHRA and NHS approval requirements; strong emphasis on health economics data"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "timeline_multiplier": 1.2,
            "regulatory_complexity_multiplier": 1.3
          },
          "notes": "FDA requirements most stringent; highest evidence generation costs globally"
        },
        "EU": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "timeline_multiplier": 1.1,
            "regulatory_complexity_multiplier": 1.2
          },
          "notes": "EMA and member state requirements; HTA evidence requirements vary by country"
        },
        "Eastern_Europe": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.75,
            "timeline_multiplier": 0.9,
            "regulatory_complexity_multiplier": 0.85
          },
          "notes": "Lower costs; variable regulatory maturity across countries"
        },
        "LATAM": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "timeline_multiplier": 0.95,
            "regulatory_complexity_multiplier": 0.8
          },
          "notes": "Cost-effective region for trials; regulatory timelines variable"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "timeline_multiplier": 0.85,
            "regulatory_complexity_multiplier": 0.75
          },
          "notes": "Rapidly developing clinical trial infrastructure; growing regulatory sophistication"
        },
        "Middle_East": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.85,
            "timeline_multiplier": 1.0,
            "regulatory_complexity_multiplier": 0.9
          },
          "notes": "Emerging clinical trial landscape; government support for research infrastructure"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_medical_affairs",
          "medical_strategy_lead"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "budget_approval_threshold_usd": 100000
        },
        "notes": "Core pillar requiring significant investment and long-term commitment"
      }
    },
    {
      "id": "patient_advocacy",
      "title": "Patient Advocacy & Insights",
      "description": "Design, execute, and manage clinical and non-clinical studies to generate evidence supporting product value proposition and addressing evidence gaps",
      "tags": [
        "clinical_trials",
        "studies",
        "research",
        "data_generation"
      ],
      "maps_strategy": {
        "strategic_intent": "Engage patient organisations and communities to understand unmet needs, incorporate insights, and support disease-state understanding ethically.",
        "scientific_narrative": {
          "core_claim": "Patient engagement improves relevance of medical strategy and helps align evidence generation and education with real needs.",
          "supporting_messages": [
            "Rigorous study design addressing key clinical and economic questions",
            "Evidence aligned with regulatory, payer, and clinical stakeholder needs",
            "Prospective data generation to complement existing evidence base"
          ],
          "data_of_interest": [
            "Clinical trial data (efficacy, safety, QoL)",
            "Health economics data (cost-effectiveness, budget impact)",
            "Patient-reported outcomes",
            "Biomarker and mechanistic data"
          ],
          "differentiators": [
            "Evidence quality and regulatory grade",
            "Comprehensive endpoints addressing multiple stakeholder needs",
            "Innovative trial designs (adaptive, pragmatic)"
          ],
          "channel_families": [
            "scientific_publications",
            "congress",
            "field_scientific_exchange"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "prelaunch_T-48_to_T-24",
            "perilaunch_T-24_to_T-12",
            "launch_T-12_to_T0",
            "postlaunch_T0_to_T12",
            "beyond_T12"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Focus on pivotal trial design and execution; early evidence generation for regulatory submissions",
            "perilaunch_T-24_to_T-12": "Complete pivotal studies; initiate post-hoc analyses and supplementary studies",
            "launch_T-12_to_T0": "Finalize study reports; prepare for publication and dissemination",
            "postlaunch_T0_to_T12": "Conduct confirmatory studies and address emerging evidence gaps"
          }
        },
        "evidence": {
          "evidence_dependency": "required",
          "evidence_gaps": [
            "Head-to-head comparator data",
            "Long-term safety and efficacy",
            "Special population data (pediatric, elderly, comorbidities)",
            "Cost-effectiveness in target markets"
          ],
          "prioritized_questions": [
            "What clinical endpoints matter most to regulators, payers, and clinicians?",
            "What study designs provide most credible evidence for stakeholder needs?",
            "How can we generate evidence efficiently while maintaining quality?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "medium",
        "base_priority_score": 0.55,
        "priority_distribution": {
          "mean": 0.55,
          "stddev": 0.12,
          "min": 0.31000000000000005,
          "max": 0.79,
          "confidence_level": "medium"
        },
        "dynamic_priority_factors": {
          "patient_burden": {
            "weight": 0.3,
            "measurement": "Disease burden and unmet need from patient perspective"
          },
          "org_maturity": {
            "weight": 0.2,
            "measurement": "Maturity and reach of patient org ecosystem"
          },
          "insight_gap": {
            "weight": 0.25,
            "measurement": "Need for patient insights to inform strategy"
          },
          "reputation_trust": {
            "weight": 0.15,
            "measurement": "Trust and perception risks to manage"
          },
          "compliance_requirements": {
            "weight": 0.1,
            "measurement": "PO engagement governance and transparency needs"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "patient_org_engagement",
          "patient_insights",
          "co_creation_workshops",
          "disease_state_education"
        ],
        "ineligible_tactic_families": [
          "medical_education",
          "digital_omnichannel"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "tier_1",
        "minimum_confidence_required": 0.65,
        "primary_stakeholder_category_keys": [
          "academia_research",
          "external_experts",
          "regulators"
        ],
        "secondary_stakeholder_category_keys": [
          "market_access_payers",
          "data_tech_partners"
        ],
        "cascade_probability_weights": {
          "evidence_generation": 0.95,
          "advisory_boards": 0.75,
          "data_partnership": 0.7
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "Real-time data streaming studies",
              "API-integrated patient registries",
              "Blockchain-verified study protocols",
              "AI-powered patient matching",
              "Decentralized clinical trials"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.3
          },
          "digital_adopter": {
            "tactics": [
              "Electronic data capture (EDC) systems",
              "Virtual study monitoring",
              "Digital consent processes",
              "Hybrid trial designs",
              "Remote patient monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.1
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional CRF with digital backup",
              "Phone-based patient follow-up",
              "Paper-digital hybrid systems",
              "In-person site visits",
              "Conventional monitoring"
            ],
            "applicability_score": 0.6,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "offline_only": {
            "tactics": [
              "Paper-based data collection",
              "Postal patient surveys",
              "In-person interviews only",
              "Traditional statistical analysis",
              "Physical site monitoring"
            ],
            "applicability_score": 0.4,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "FDA-preapproved study protocols",
              "Independent data monitoring committee",
              "Third-party statistical analysis",
              "Full audit trail documentation",
              "GCP-compliant operations"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.4
          },
          "high": {
            "tactics": [
              "IRB-approved protocols",
              "Regular compliance monitoring",
              "Standard audit procedures",
              "Documentation requirements",
              "Quality assurance protocols"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "medium": {
            "tactics": [
              "Standard ethical approval",
              "Routine monitoring",
              "Basic documentation",
              "Standard reporting",
              "Internal QA reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Minimal approval requirements",
              "Self-monitoring protocols",
              "Streamlined documentation",
              "Simplified reporting",
              "Basic oversight"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_data_sensitivity": {
          "very_high": {
            "tactics": [
              "De-identification at source",
              "Encrypted data transmission",
              "Secure multi-party computation",
              "Zero-knowledge proof protocols",
              "Federated learning approaches"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.35
          },
          "high": {
            "tactics": [
              "Pseudonymization protocols",
              "Encrypted databases",
              "Access control systems",
              "Regular security audits",
              "Privacy-preserving analytics"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "high",
            "cost_multiplier": 1.15
          },
          "medium": {
            "tactics": [
              "Standard data protection",
              "Basic encryption",
              "User authentication",
              "Periodic reviews",
              "Standard privacy measures"
            ],
            "applicability_score": 0.65,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Basic anonymization",
              "Standard security",
              "Simple access controls",
              "Minimal restrictions",
              "Standard data handling"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_cross_border": {
          "restricted": {
            "tactics": [
              "Country-specific protocols",
              "Local PI requirements",
              "Regional data centers",
              "Jurisdiction-specific approvals",
              "Local ethics committees"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "unrestricted": {
            "tactics": [
              "Global protocol harmonization",
              "Central data management",
              "Unified approval processes",
              "Cross-border data sharing",
              "International coordination"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 500000,
          "typical": 2000000,
          "max": 10000000
        },
        "resource_requirements": {
          "ftes": {
            "clinical_operations_lead": 0.5,
            "clinical_project_manager": 1.0,
            "clinical_research_associates": 2.0,
            "data_manager": 0.5,
            "medical_monitor": 0.25,
            "biostatistician": 0.3
          },
          "external_vendors": [
            "CRO (clinical research organization)",
            "central_lab",
            "imaging_core_lab",
            "data_management_vendor"
          ]
        },
        "timeline_estimate_months": {
          "min": 12,
          "typical": 24,
          "max": 48
        },
        "roi_metrics": {
          "primary": "evidence_quality_score",
          "secondary": [
            "regulatory_approval_acceleration",
            "payer_coverage_probability",
            "publication_impact_factor"
          ],
          "expected_roi_range": [
            2.0,
            5.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.9,
            "notes": "Must have governance framework before initiating studies"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "kol_engagement",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOL involvement improves study design and enrollment"
          },
          {
            "pillar_id": "publications",
            "dependency_type": "sequential",
            "strength": 0.85,
            "notes": "Evidence generation feeds publication strategy"
          }
        ],
        "enables": [
          "evidence_interpretation",
          "market_access_support",
          "publications"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.1,
            "timeline_multiplier": 1.05,
            "regulatory_complexity_multiplier": 1.15
          },
          "notes": "MHRA and NHS approval requirements; strong emphasis on health economics data"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "timeline_multiplier": 1.2,
            "regulatory_complexity_multiplier": 1.3
          },
          "notes": "FDA requirements most stringent; highest evidence generation costs globally"
        },
        "EU": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "timeline_multiplier": 1.1,
            "regulatory_complexity_multiplier": 1.2
          },
          "notes": "EMA and member state requirements; HTA evidence requirements vary by country"
        },
        "Eastern_Europe": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.75,
            "timeline_multiplier": 0.9,
            "regulatory_complexity_multiplier": 0.85
          },
          "notes": "Lower costs; variable regulatory maturity across countries"
        },
        "LATAM": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "timeline_multiplier": 0.95,
            "regulatory_complexity_multiplier": 0.8
          },
          "notes": "Cost-effective region for trials; regulatory timelines variable"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "timeline_multiplier": 0.85,
            "regulatory_complexity_multiplier": 0.75
          },
          "notes": "Rapidly developing clinical trial infrastructure; growing regulatory sophistication"
        },
        "Middle_East": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.85,
            "timeline_multiplier": 1.0,
            "regulatory_complexity_multiplier": 0.9
          },
          "notes": "Emerging clinical trial landscape; government support for research infrastructure"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_medical_affairs",
          "medical_strategy_lead",
          "patient_engagement_lead"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "budget_approval_threshold_usd": 100000
        },
        "notes": "Core pillar requiring significant investment and long-term commitment"
      }
    },
    {
      "id": "market_access_support",
      "title": "Market Access Support",
      "description": "Design, execute, and manage clinical and non-clinical studies to generate evidence supporting product value proposition and addressing evidence gaps",
      "tags": [
        "clinical_trials",
        "studies",
        "research",
        "data_generation"
      ],
      "maps_strategy": {
        "strategic_intent": "Support payer and HTA evidence needs through robust value narrative inputs, HEOR/RWE planning, and scientific exchange with access stakeholders.",
        "scientific_narrative": {
          "core_claim": "Access decisions are supported by credible evidence packages aligned to payer/HTA requirements and local pathways.",
          "supporting_messages": [
            "Rigorous study design addressing key clinical and economic questions",
            "Evidence aligned with regulatory, payer, and clinical stakeholder needs",
            "Prospective data generation to complement existing evidence base"
          ],
          "data_of_interest": [
            "Clinical trial data (efficacy, safety, QoL)",
            "Health economics data (cost-effectiveness, budget impact)",
            "Patient-reported outcomes",
            "Biomarker and mechanistic data"
          ],
          "differentiators": [
            "Evidence quality and regulatory grade",
            "Comprehensive endpoints addressing multiple stakeholder needs",
            "Innovative trial designs (adaptive, pragmatic)"
          ],
          "channel_families": [
            "scientific_publications",
            "congress",
            "field_scientific_exchange"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "prelaunch_T-48_to_T-24",
            "perilaunch_T-24_to_T-12",
            "launch_T-12_to_T0",
            "postlaunch_T0_to_T12"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Focus on pivotal trial design and execution; early evidence generation for regulatory submissions",
            "perilaunch_T-24_to_T-12": "Complete pivotal studies; initiate post-hoc analyses and supplementary studies",
            "launch_T-12_to_T0": "Finalize study reports; prepare for publication and dissemination",
            "postlaunch_T0_to_T12": "Conduct confirmatory studies and address emerging evidence gaps"
          }
        },
        "evidence": {
          "evidence_dependency": "required",
          "evidence_gaps": [
            "Head-to-head comparator data",
            "Long-term safety and efficacy",
            "Special population data (pediatric, elderly, comorbidities)",
            "Cost-effectiveness in target markets"
          ],
          "prioritized_questions": [
            "What clinical endpoints matter most to regulators, payers, and clinicians?",
            "What study designs provide most credible evidence for stakeholder needs?",
            "How can we generate evidence efficiently while maintaining quality?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "very_high",
        "base_priority_score": 0.85,
        "priority_distribution": {
          "mean": 0.85,
          "stddev": 0.08,
          "min": 0.69,
          "max": 0.99,
          "confidence_level": "high"
        },
        "dynamic_priority_factors": {
          "hta_rigor": {
            "weight": 0.3,
            "measurement": "Stringency of local HTA and evidence standards"
          },
          "evidence_gap_criticality": {
            "weight": 0.25,
            "measurement": "Critical evidence gaps for access/reimbursement"
          },
          "comparative_evidence_need": {
            "weight": 0.2,
            "measurement": "Need for comparative effectiveness and QoL evidence"
          },
          "timeline_pressure": {
            "weight": 0.15,
            "measurement": "Proximity to submission/decision milestones"
          },
          "resource_availability": {
            "weight": 0.1,
            "measurement": "HEOR/RWE resourcing"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "heor_strategy",
          "payer_evidence_support",
          "value_dossier_scientific_input",
          "hta_engagement_support"
        ],
        "ineligible_tactic_families": [
          "medical_education",
          "digital_omnichannel"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "tier_2",
        "minimum_confidence_required": 0.75,
        "primary_stakeholder_category_keys": [
          "academia_research",
          "external_experts",
          "regulators"
        ],
        "secondary_stakeholder_category_keys": [
          "market_access_payers",
          "data_tech_partners"
        ],
        "cascade_probability_weights": {
          "evidence_generation": 0.95,
          "advisory_boards": 0.75,
          "data_partnership": 0.7
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "Real-time data streaming studies",
              "API-integrated patient registries",
              "Blockchain-verified study protocols",
              "AI-powered patient matching",
              "Decentralized clinical trials"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.3
          },
          "digital_adopter": {
            "tactics": [
              "Electronic data capture (EDC) systems",
              "Virtual study monitoring",
              "Digital consent processes",
              "Hybrid trial designs",
              "Remote patient monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.1
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional CRF with digital backup",
              "Phone-based patient follow-up",
              "Paper-digital hybrid systems",
              "In-person site visits",
              "Conventional monitoring"
            ],
            "applicability_score": 0.6,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "offline_only": {
            "tactics": [
              "Paper-based data collection",
              "Postal patient surveys",
              "In-person interviews only",
              "Traditional statistical analysis",
              "Physical site monitoring"
            ],
            "applicability_score": 0.4,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "FDA-preapproved study protocols",
              "Independent data monitoring committee",
              "Third-party statistical analysis",
              "Full audit trail documentation",
              "GCP-compliant operations"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.4
          },
          "high": {
            "tactics": [
              "IRB-approved protocols",
              "Regular compliance monitoring",
              "Standard audit procedures",
              "Documentation requirements",
              "Quality assurance protocols"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "medium": {
            "tactics": [
              "Standard ethical approval",
              "Routine monitoring",
              "Basic documentation",
              "Standard reporting",
              "Internal QA reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Minimal approval requirements",
              "Self-monitoring protocols",
              "Streamlined documentation",
              "Simplified reporting",
              "Basic oversight"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_data_sensitivity": {
          "very_high": {
            "tactics": [
              "De-identification at source",
              "Encrypted data transmission",
              "Secure multi-party computation",
              "Zero-knowledge proof protocols",
              "Federated learning approaches"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.35
          },
          "high": {
            "tactics": [
              "Pseudonymization protocols",
              "Encrypted databases",
              "Access control systems",
              "Regular security audits",
              "Privacy-preserving analytics"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "high",
            "cost_multiplier": 1.15
          },
          "medium": {
            "tactics": [
              "Standard data protection",
              "Basic encryption",
              "User authentication",
              "Periodic reviews",
              "Standard privacy measures"
            ],
            "applicability_score": 0.65,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Basic anonymization",
              "Standard security",
              "Simple access controls",
              "Minimal restrictions",
              "Standard data handling"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_cross_border": {
          "restricted": {
            "tactics": [
              "Country-specific protocols",
              "Local PI requirements",
              "Regional data centers",
              "Jurisdiction-specific approvals",
              "Local ethics committees"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "unrestricted": {
            "tactics": [
              "Global protocol harmonization",
              "Central data management",
              "Unified approval processes",
              "Cross-border data sharing",
              "International coordination"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 500000,
          "typical": 2000000,
          "max": 10000000
        },
        "resource_requirements": {
          "ftes": {
            "clinical_operations_lead": 0.5,
            "clinical_project_manager": 1.0,
            "clinical_research_associates": 2.0,
            "data_manager": 0.5,
            "medical_monitor": 0.25,
            "biostatistician": 0.3
          },
          "external_vendors": [
            "CRO (clinical research organization)",
            "central_lab",
            "imaging_core_lab",
            "data_management_vendor"
          ]
        },
        "timeline_estimate_months": {
          "min": 12,
          "typical": 24,
          "max": 48
        },
        "roi_metrics": {
          "primary": "evidence_quality_score",
          "secondary": [
            "regulatory_approval_acceleration",
            "payer_coverage_probability",
            "publication_impact_factor"
          ],
          "expected_roi_range": [
            2.0,
            5.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.9,
            "notes": "Must have governance framework before initiating studies"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "kol_engagement",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOL involvement improves study design and enrollment"
          },
          {
            "pillar_id": "publications",
            "dependency_type": "sequential",
            "strength": 0.85,
            "notes": "Evidence generation feeds publication strategy"
          }
        ],
        "enables": [
          "evidence_interpretation",
          "market_access_support",
          "publications"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.1,
            "timeline_multiplier": 1.05,
            "regulatory_complexity_multiplier": 1.15
          },
          "notes": "MHRA and NHS approval requirements; strong emphasis on health economics data"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "timeline_multiplier": 1.2,
            "regulatory_complexity_multiplier": 1.3
          },
          "notes": "FDA requirements most stringent; highest evidence generation costs globally"
        },
        "EU": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "timeline_multiplier": 1.1,
            "regulatory_complexity_multiplier": 1.2
          },
          "notes": "EMA and member state requirements; HTA evidence requirements vary by country"
        },
        "Eastern_Europe": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.75,
            "timeline_multiplier": 0.9,
            "regulatory_complexity_multiplier": 0.85
          },
          "notes": "Lower costs; variable regulatory maturity across countries"
        },
        "LATAM": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "timeline_multiplier": 0.95,
            "regulatory_complexity_multiplier": 0.8
          },
          "notes": "Cost-effective region for trials; regulatory timelines variable"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "timeline_multiplier": 0.85,
            "regulatory_complexity_multiplier": 0.75
          },
          "notes": "Rapidly developing clinical trial infrastructure; growing regulatory sophistication"
        },
        "Middle_East": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.85,
            "timeline_multiplier": 1.0,
            "regulatory_complexity_multiplier": 0.9
          },
          "notes": "Emerging clinical trial landscape; government support for research infrastructure"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_medical_affairs",
          "medical_strategy_lead",
          "heor_lead"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "budget_approval_threshold_usd": 100000
        },
        "notes": "Core pillar requiring significant investment and long-term commitment"
      }
    },
    {
      "id": "digital_omnichannel",
      "title": "Digital & Omnichannel Engagement",
      "description": "Design, execute, and manage clinical and non-clinical studies to generate evidence supporting product value proposition and addressing evidence gaps",
      "tags": [
        "clinical_trials",
        "studies",
        "research",
        "data_generation"
      ],
      "maps_strategy": {
        "strategic_intent": "Deliver consistent scientific value through orchestrated digital and hybrid channels, increasing reach while maintaining compliance and measurement rigor.",
        "scientific_narrative": {
          "core_claim": "Omnichannel scientific engagement improves reach and consistency while preserving scientific integrity and auditability.",
          "supporting_messages": [
            "Rigorous study design addressing key clinical and economic questions",
            "Evidence aligned with regulatory, payer, and clinical stakeholder needs",
            "Prospective data generation to complement existing evidence base"
          ],
          "data_of_interest": [
            "Clinical trial data (efficacy, safety, QoL)",
            "Health economics data (cost-effectiveness, budget impact)",
            "Patient-reported outcomes",
            "Biomarker and mechanistic data"
          ],
          "differentiators": [
            "Evidence quality and regulatory grade",
            "Comprehensive endpoints addressing multiple stakeholder needs",
            "Innovative trial designs (adaptive, pragmatic)"
          ],
          "channel_families": [
            "scientific_publications",
            "congress",
            "field_scientific_exchange"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "launch_T-12_to_T0",
            "postlaunch_T0_to_T12",
            "beyond_T12"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Focus on pivotal trial design and execution; early evidence generation for regulatory submissions",
            "perilaunch_T-24_to_T-12": "Complete pivotal studies; initiate post-hoc analyses and supplementary studies",
            "launch_T-12_to_T0": "Finalize study reports; prepare for publication and dissemination",
            "postlaunch_T0_to_T12": "Conduct confirmatory studies and address emerging evidence gaps"
          }
        },
        "evidence": {
          "evidence_dependency": "required",
          "evidence_gaps": [
            "Head-to-head comparator data",
            "Long-term safety and efficacy",
            "Special population data (pediatric, elderly, comorbidities)",
            "Cost-effectiveness in target markets"
          ],
          "prioritized_questions": [
            "What clinical endpoints matter most to regulators, payers, and clinicians?",
            "What study designs provide most credible evidence for stakeholder needs?",
            "How can we generate evidence efficiently while maintaining quality?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "medium",
        "base_priority_score": 0.55,
        "priority_distribution": {
          "mean": 0.55,
          "stddev": 0.12,
          "min": 0.31000000000000005,
          "max": 0.79,
          "confidence_level": "medium"
        },
        "dynamic_priority_factors": {
          "digital_maturity": {
            "weight": 0.3,
            "measurement": "Readiness of markets and teams for digital execution"
          },
          "reach_gap": {
            "weight": 0.2,
            "measurement": "Need to scale engagement beyond field capacity"
          },
          "measurement_readiness": {
            "weight": 0.2,
            "measurement": "Ability to measure outcomes and iterate"
          },
          "compliance_risk": {
            "weight": 0.2,
            "measurement": "Digital governance and local requirements"
          },
          "content_capacity": {
            "weight": 0.1,
            "measurement": "Content production and review capacity"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "omnichannel_orchestration",
          "webinars_virtual_events",
          "digital_content_hubs",
          "email_scientific_updates"
        ],
        "ineligible_tactic_families": [
          "medical_education",
          "digital_omnichannel"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "tier_1",
        "minimum_confidence_required": 0.65,
        "primary_stakeholder_category_keys": [
          "academia_research",
          "external_experts",
          "regulators"
        ],
        "secondary_stakeholder_category_keys": [
          "market_access_payers",
          "data_tech_partners"
        ],
        "cascade_probability_weights": {
          "evidence_generation": 0.95,
          "advisory_boards": 0.75,
          "data_partnership": 0.7
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "Real-time data streaming studies",
              "API-integrated patient registries",
              "Blockchain-verified study protocols",
              "AI-powered patient matching",
              "Decentralized clinical trials"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.3
          },
          "digital_adopter": {
            "tactics": [
              "Electronic data capture (EDC) systems",
              "Virtual study monitoring",
              "Digital consent processes",
              "Hybrid trial designs",
              "Remote patient monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.1
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional CRF with digital backup",
              "Phone-based patient follow-up",
              "Paper-digital hybrid systems",
              "In-person site visits",
              "Conventional monitoring"
            ],
            "applicability_score": 0.6,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "offline_only": {
            "tactics": [
              "Paper-based data collection",
              "Postal patient surveys",
              "In-person interviews only",
              "Traditional statistical analysis",
              "Physical site monitoring"
            ],
            "applicability_score": 0.4,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "FDA-preapproved study protocols",
              "Independent data monitoring committee",
              "Third-party statistical analysis",
              "Full audit trail documentation",
              "GCP-compliant operations"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.4
          },
          "high": {
            "tactics": [
              "IRB-approved protocols",
              "Regular compliance monitoring",
              "Standard audit procedures",
              "Documentation requirements",
              "Quality assurance protocols"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "medium": {
            "tactics": [
              "Standard ethical approval",
              "Routine monitoring",
              "Basic documentation",
              "Standard reporting",
              "Internal QA reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Minimal approval requirements",
              "Self-monitoring protocols",
              "Streamlined documentation",
              "Simplified reporting",
              "Basic oversight"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_data_sensitivity": {
          "very_high": {
            "tactics": [
              "De-identification at source",
              "Encrypted data transmission",
              "Secure multi-party computation",
              "Zero-knowledge proof protocols",
              "Federated learning approaches"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.35
          },
          "high": {
            "tactics": [
              "Pseudonymization protocols",
              "Encrypted databases",
              "Access control systems",
              "Regular security audits",
              "Privacy-preserving analytics"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "high",
            "cost_multiplier": 1.15
          },
          "medium": {
            "tactics": [
              "Standard data protection",
              "Basic encryption",
              "User authentication",
              "Periodic reviews",
              "Standard privacy measures"
            ],
            "applicability_score": 0.65,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Basic anonymization",
              "Standard security",
              "Simple access controls",
              "Minimal restrictions",
              "Standard data handling"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_cross_border": {
          "restricted": {
            "tactics": [
              "Country-specific protocols",
              "Local PI requirements",
              "Regional data centers",
              "Jurisdiction-specific approvals",
              "Local ethics committees"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "unrestricted": {
            "tactics": [
              "Global protocol harmonization",
              "Central data management",
              "Unified approval processes",
              "Cross-border data sharing",
              "International coordination"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 500000,
          "typical": 2000000,
          "max": 10000000
        },
        "resource_requirements": {
          "ftes": {
            "clinical_operations_lead": 0.5,
            "clinical_project_manager": 1.0,
            "clinical_research_associates": 2.0,
            "data_manager": 0.5,
            "medical_monitor": 0.25,
            "biostatistician": 0.3
          },
          "external_vendors": [
            "CRO (clinical research organization)",
            "central_lab",
            "imaging_core_lab",
            "data_management_vendor"
          ]
        },
        "timeline_estimate_months": {
          "min": 12,
          "typical": 24,
          "max": 48
        },
        "roi_metrics": {
          "primary": "evidence_quality_score",
          "secondary": [
            "regulatory_approval_acceleration",
            "payer_coverage_probability",
            "publication_impact_factor"
          ],
          "expected_roi_range": [
            2.0,
            5.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.9,
            "notes": "Must have governance framework before initiating studies"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "kol_engagement",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOL involvement improves study design and enrollment"
          },
          {
            "pillar_id": "publications",
            "dependency_type": "sequential",
            "strength": 0.85,
            "notes": "Evidence generation feeds publication strategy"
          }
        ],
        "enables": [
          "evidence_interpretation",
          "market_access_support",
          "publications"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.1,
            "timeline_multiplier": 1.05,
            "regulatory_complexity_multiplier": 1.15
          },
          "notes": "MHRA and NHS approval requirements; strong emphasis on health economics data"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "timeline_multiplier": 1.2,
            "regulatory_complexity_multiplier": 1.3
          },
          "notes": "FDA requirements most stringent; highest evidence generation costs globally"
        },
        "EU": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "timeline_multiplier": 1.1,
            "regulatory_complexity_multiplier": 1.2
          },
          "notes": "EMA and member state requirements; HTA evidence requirements vary by country"
        },
        "Eastern_Europe": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.75,
            "timeline_multiplier": 0.9,
            "regulatory_complexity_multiplier": 0.85
          },
          "notes": "Lower costs; variable regulatory maturity across countries"
        },
        "LATAM": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "timeline_multiplier": 0.95,
            "regulatory_complexity_multiplier": 0.8
          },
          "notes": "Cost-effective region for trials; regulatory timelines variable"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "timeline_multiplier": 0.85,
            "regulatory_complexity_multiplier": 0.75
          },
          "notes": "Rapidly developing clinical trial infrastructure; growing regulatory sophistication"
        },
        "Middle_East": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.85,
            "timeline_multiplier": 1.0,
            "regulatory_complexity_multiplier": 0.9
          },
          "notes": "Emerging clinical trial landscape; government support for research infrastructure"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_medical_affairs",
          "medical_strategy_lead"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "budget_approval_threshold_usd": 100000
        },
        "notes": "Core pillar requiring significant investment and long-term commitment"
      }
    },
    {
      "id": "field_medical",
      "title": "Field Medical Excellence",
      "description": "Design, execute, and manage clinical and non-clinical studies to generate evidence supporting product value proposition and addressing evidence gaps",
      "tags": [
        "clinical_trials",
        "studies",
        "research",
        "data_generation"
      ],
      "maps_strategy": {
        "strategic_intent": "Operationalise field medical excellence to deliver high-quality scientific interactions, insight capture, and territory prioritisation across the lifecycle.",
        "scientific_narrative": {
          "core_claim": "Field medical execution is consistent, insight-driven, and aligned to strategy with measurable standards of quality.",
          "supporting_messages": [
            "Rigorous study design addressing key clinical and economic questions",
            "Evidence aligned with regulatory, payer, and clinical stakeholder needs",
            "Prospective data generation to complement existing evidence base"
          ],
          "data_of_interest": [
            "Clinical trial data (efficacy, safety, QoL)",
            "Health economics data (cost-effectiveness, budget impact)",
            "Patient-reported outcomes",
            "Biomarker and mechanistic data"
          ],
          "differentiators": [
            "Evidence quality and regulatory grade",
            "Comprehensive endpoints addressing multiple stakeholder needs",
            "Innovative trial designs (adaptive, pragmatic)"
          ],
          "channel_families": [
            "scientific_publications",
            "congress",
            "field_scientific_exchange"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "launch_T-12_to_T0",
            "postlaunch_T0_to_T12",
            "beyond_T12"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Focus on pivotal trial design and execution; early evidence generation for regulatory submissions",
            "perilaunch_T-24_to_T-12": "Complete pivotal studies; initiate post-hoc analyses and supplementary studies",
            "launch_T-12_to_T0": "Finalize study reports; prepare for publication and dissemination",
            "postlaunch_T0_to_T12": "Conduct confirmatory studies and address emerging evidence gaps"
          }
        },
        "evidence": {
          "evidence_dependency": "required",
          "evidence_gaps": [
            "Head-to-head comparator data",
            "Long-term safety and efficacy",
            "Special population data (pediatric, elderly, comorbidities)",
            "Cost-effectiveness in target markets"
          ],
          "prioritized_questions": [
            "What clinical endpoints matter most to regulators, payers, and clinicians?",
            "What study designs provide most credible evidence for stakeholder needs?",
            "How can we generate evidence efficiently while maintaining quality?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "high",
        "base_priority_score": 0.75,
        "priority_distribution": {
          "mean": 0.75,
          "stddev": 0.1,
          "min": 0.55,
          "max": 0.95,
          "confidence_level": "high"
        },
        "dynamic_priority_factors": {
          "coverage_gap": {
            "weight": 0.3,
            "measurement": "Mismatch between stakeholder needs and field coverage"
          },
          "insight_value": {
            "weight": 0.25,
            "measurement": "Expected strategic value of insights captured"
          },
          "execution_quality_risk": {
            "weight": 0.2,
            "measurement": "Risk of inconsistent engagement quality"
          },
          "training_needs": {
            "weight": 0.15,
            "measurement": "Capability gaps and onboarding demand"
          },
          "resource_availability": {
            "weight": 0.1,
            "measurement": "MSL headcount and travel budget"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "field_medical_operating_model",
          "territory_prioritisation",
          "insight_capture_systems",
          "msl_capability_building"
        ],
        "ineligible_tactic_families": [
          "medical_education",
          "digital_omnichannel"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "tier_2",
        "minimum_confidence_required": 0.75,
        "primary_stakeholder_category_keys": [
          "academia_research",
          "external_experts",
          "regulators"
        ],
        "secondary_stakeholder_category_keys": [
          "market_access_payers",
          "data_tech_partners"
        ],
        "cascade_probability_weights": {
          "evidence_generation": 0.95,
          "advisory_boards": 0.75,
          "data_partnership": 0.7
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "Real-time data streaming studies",
              "API-integrated patient registries",
              "Blockchain-verified study protocols",
              "AI-powered patient matching",
              "Decentralized clinical trials"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.3
          },
          "digital_adopter": {
            "tactics": [
              "Electronic data capture (EDC) systems",
              "Virtual study monitoring",
              "Digital consent processes",
              "Hybrid trial designs",
              "Remote patient monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.1
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional CRF with digital backup",
              "Phone-based patient follow-up",
              "Paper-digital hybrid systems",
              "In-person site visits",
              "Conventional monitoring"
            ],
            "applicability_score": 0.6,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "offline_only": {
            "tactics": [
              "Paper-based data collection",
              "Postal patient surveys",
              "In-person interviews only",
              "Traditional statistical analysis",
              "Physical site monitoring"
            ],
            "applicability_score": 0.4,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "FDA-preapproved study protocols",
              "Independent data monitoring committee",
              "Third-party statistical analysis",
              "Full audit trail documentation",
              "GCP-compliant operations"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.4
          },
          "high": {
            "tactics": [
              "IRB-approved protocols",
              "Regular compliance monitoring",
              "Standard audit procedures",
              "Documentation requirements",
              "Quality assurance protocols"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "medium": {
            "tactics": [
              "Standard ethical approval",
              "Routine monitoring",
              "Basic documentation",
              "Standard reporting",
              "Internal QA reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Minimal approval requirements",
              "Self-monitoring protocols",
              "Streamlined documentation",
              "Simplified reporting",
              "Basic oversight"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_data_sensitivity": {
          "very_high": {
            "tactics": [
              "De-identification at source",
              "Encrypted data transmission",
              "Secure multi-party computation",
              "Zero-knowledge proof protocols",
              "Federated learning approaches"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.35
          },
          "high": {
            "tactics": [
              "Pseudonymization protocols",
              "Encrypted databases",
              "Access control systems",
              "Regular security audits",
              "Privacy-preserving analytics"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "high",
            "cost_multiplier": 1.15
          },
          "medium": {
            "tactics": [
              "Standard data protection",
              "Basic encryption",
              "User authentication",
              "Periodic reviews",
              "Standard privacy measures"
            ],
            "applicability_score": 0.65,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Basic anonymization",
              "Standard security",
              "Simple access controls",
              "Minimal restrictions",
              "Standard data handling"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_cross_border": {
          "restricted": {
            "tactics": [
              "Country-specific protocols",
              "Local PI requirements",
              "Regional data centers",
              "Jurisdiction-specific approvals",
              "Local ethics committees"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "unrestricted": {
            "tactics": [
              "Global protocol harmonization",
              "Central data management",
              "Unified approval processes",
              "Cross-border data sharing",
              "International coordination"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 500000,
          "typical": 2000000,
          "max": 10000000
        },
        "resource_requirements": {
          "ftes": {
            "clinical_operations_lead": 0.5,
            "clinical_project_manager": 1.0,
            "clinical_research_associates": 2.0,
            "data_manager": 0.5,
            "medical_monitor": 0.25,
            "biostatistician": 0.3
          },
          "external_vendors": [
            "CRO (clinical research organization)",
            "central_lab",
            "imaging_core_lab",
            "data_management_vendor"
          ]
        },
        "timeline_estimate_months": {
          "min": 12,
          "typical": 24,
          "max": 48
        },
        "roi_metrics": {
          "primary": "evidence_quality_score",
          "secondary": [
            "regulatory_approval_acceleration",
            "payer_coverage_probability",
            "publication_impact_factor"
          ],
          "expected_roi_range": [
            2.0,
            5.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.9,
            "notes": "Must have governance framework before initiating studies"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "kol_engagement",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOL involvement improves study design and enrollment"
          },
          {
            "pillar_id": "publications",
            "dependency_type": "sequential",
            "strength": 0.85,
            "notes": "Evidence generation feeds publication strategy"
          }
        ],
        "enables": [
          "evidence_interpretation",
          "market_access_support",
          "publications"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.1,
            "timeline_multiplier": 1.05,
            "regulatory_complexity_multiplier": 1.15
          },
          "notes": "MHRA and NHS approval requirements; strong emphasis on health economics data"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "timeline_multiplier": 1.2,
            "regulatory_complexity_multiplier": 1.3
          },
          "notes": "FDA requirements most stringent; highest evidence generation costs globally"
        },
        "EU": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "timeline_multiplier": 1.1,
            "regulatory_complexity_multiplier": 1.2
          },
          "notes": "EMA and member state requirements; HTA evidence requirements vary by country"
        },
        "Eastern_Europe": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.75,
            "timeline_multiplier": 0.9,
            "regulatory_complexity_multiplier": 0.85
          },
          "notes": "Lower costs; variable regulatory maturity across countries"
        },
        "LATAM": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "timeline_multiplier": 0.95,
            "regulatory_complexity_multiplier": 0.8
          },
          "notes": "Cost-effective region for trials; regulatory timelines variable"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "timeline_multiplier": 0.85,
            "regulatory_complexity_multiplier": 0.75
          },
          "notes": "Rapidly developing clinical trial infrastructure; growing regulatory sophistication"
        },
        "Middle_East": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.85,
            "timeline_multiplier": 1.0,
            "regulatory_complexity_multiplier": 0.9
          },
          "notes": "Emerging clinical trial landscape; government support for research infrastructure"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_medical_affairs",
          "medical_strategy_lead",
          "field_medical_lead"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "budget_approval_threshold_usd": 100000
        },
        "notes": "Core pillar requiring significant investment and long-term commitment"
      }
    },
    {
      "id": "internal_alignment",
      "title": "Internal Alignment & Training",
      "description": "Design, execute, and manage clinical and non-clinical studies to generate evidence supporting product value proposition and addressing evidence gaps",
      "tags": [
        "clinical_trials",
        "studies",
        "research",
        "data_generation"
      ],
      "maps_strategy": {
        "strategic_intent": "Ensure internal medical readiness through training, cross-functional alignment, and clear governance for launch and lifecycle execution.",
        "scientific_narrative": {
          "core_claim": "Aligned internal teams execute faster, with fewer compliance issues and higher consistency of scientific narrative.",
          "supporting_messages": [
            "Rigorous study design addressing key clinical and economic questions",
            "Evidence aligned with regulatory, payer, and clinical stakeholder needs",
            "Prospective data generation to complement existing evidence base"
          ],
          "data_of_interest": [
            "Clinical trial data (efficacy, safety, QoL)",
            "Health economics data (cost-effectiveness, budget impact)",
            "Patient-reported outcomes",
            "Biomarker and mechanistic data"
          ],
          "differentiators": [
            "Evidence quality and regulatory grade",
            "Comprehensive endpoints addressing multiple stakeholder needs",
            "Innovative trial designs (adaptive, pragmatic)"
          ],
          "channel_families": [
            "scientific_publications",
            "congress",
            "field_scientific_exchange"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "prelaunch_T-48_to_T-24",
            "perilaunch_T-24_to_T-12",
            "launch_T-12_to_T0"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Focus on pivotal trial design and execution; early evidence generation for regulatory submissions",
            "perilaunch_T-24_to_T-12": "Complete pivotal studies; initiate post-hoc analyses and supplementary studies",
            "launch_T-12_to_T0": "Finalize study reports; prepare for publication and dissemination",
            "postlaunch_T0_to_T12": "Conduct confirmatory studies and address emerging evidence gaps"
          }
        },
        "evidence": {
          "evidence_dependency": "required",
          "evidence_gaps": [
            "Head-to-head comparator data",
            "Long-term safety and efficacy",
            "Special population data (pediatric, elderly, comorbidities)",
            "Cost-effectiveness in target markets"
          ],
          "prioritized_questions": [
            "What clinical endpoints matter most to regulators, payers, and clinicians?",
            "What study designs provide most credible evidence for stakeholder needs?",
            "How can we generate evidence efficiently while maintaining quality?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "medium",
        "base_priority_score": 0.55,
        "priority_distribution": {
          "mean": 0.55,
          "stddev": 0.12,
          "min": 0.31000000000000005,
          "max": 0.79,
          "confidence_level": "medium"
        },
        "dynamic_priority_factors": {
          "complexity_of_launch": {
            "weight": 0.3,
            "measurement": "Launch complexity and cross-functional dependencies"
          },
          "capability_gap": {
            "weight": 0.25,
            "measurement": "Magnitude of training and readiness gaps"
          },
          "time_to_launch": {
            "weight": 0.2,
            "measurement": "Proximity to launch milestones"
          },
          "process_maturity": {
            "weight": 0.15,
            "measurement": "Maturity of SOPs and governance"
          },
          "resource_availability": {
            "weight": 0.1,
            "measurement": "Availability of trainers and materials"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "internal_training",
          "launch_readiness",
          "cross_functional_alignment",
          "scientific_narrative_enablement"
        ],
        "ineligible_tactic_families": [
          "medical_education",
          "digital_omnichannel"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "tier_1",
        "minimum_confidence_required": 0.65,
        "primary_stakeholder_category_keys": [
          "academia_research",
          "external_experts",
          "regulators"
        ],
        "secondary_stakeholder_category_keys": [
          "market_access_payers",
          "data_tech_partners"
        ],
        "cascade_probability_weights": {
          "evidence_generation": 0.95,
          "advisory_boards": 0.75,
          "data_partnership": 0.7
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "Real-time data streaming studies",
              "API-integrated patient registries",
              "Blockchain-verified study protocols",
              "AI-powered patient matching",
              "Decentralized clinical trials"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.3
          },
          "digital_adopter": {
            "tactics": [
              "Electronic data capture (EDC) systems",
              "Virtual study monitoring",
              "Digital consent processes",
              "Hybrid trial designs",
              "Remote patient monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.1
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional CRF with digital backup",
              "Phone-based patient follow-up",
              "Paper-digital hybrid systems",
              "In-person site visits",
              "Conventional monitoring"
            ],
            "applicability_score": 0.6,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "offline_only": {
            "tactics": [
              "Paper-based data collection",
              "Postal patient surveys",
              "In-person interviews only",
              "Traditional statistical analysis",
              "Physical site monitoring"
            ],
            "applicability_score": 0.4,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "FDA-preapproved study protocols",
              "Independent data monitoring committee",
              "Third-party statistical analysis",
              "Full audit trail documentation",
              "GCP-compliant operations"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.4
          },
          "high": {
            "tactics": [
              "IRB-approved protocols",
              "Regular compliance monitoring",
              "Standard audit procedures",
              "Documentation requirements",
              "Quality assurance protocols"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "medium": {
            "tactics": [
              "Standard ethical approval",
              "Routine monitoring",
              "Basic documentation",
              "Standard reporting",
              "Internal QA reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Minimal approval requirements",
              "Self-monitoring protocols",
              "Streamlined documentation",
              "Simplified reporting",
              "Basic oversight"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_data_sensitivity": {
          "very_high": {
            "tactics": [
              "De-identification at source",
              "Encrypted data transmission",
              "Secure multi-party computation",
              "Zero-knowledge proof protocols",
              "Federated learning approaches"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.35
          },
          "high": {
            "tactics": [
              "Pseudonymization protocols",
              "Encrypted databases",
              "Access control systems",
              "Regular security audits",
              "Privacy-preserving analytics"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "high",
            "cost_multiplier": 1.15
          },
          "medium": {
            "tactics": [
              "Standard data protection",
              "Basic encryption",
              "User authentication",
              "Periodic reviews",
              "Standard privacy measures"
            ],
            "applicability_score": 0.65,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Basic anonymization",
              "Standard security",
              "Simple access controls",
              "Minimal restrictions",
              "Standard data handling"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_cross_border": {
          "restricted": {
            "tactics": [
              "Country-specific protocols",
              "Local PI requirements",
              "Regional data centers",
              "Jurisdiction-specific approvals",
              "Local ethics committees"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "unrestricted": {
            "tactics": [
              "Global protocol harmonization",
              "Central data management",
              "Unified approval processes",
              "Cross-border data sharing",
              "International coordination"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 500000,
          "typical": 2000000,
          "max": 10000000
        },
        "resource_requirements": {
          "ftes": {
            "clinical_operations_lead": 0.5,
            "clinical_project_manager": 1.0,
            "clinical_research_associates": 2.0,
            "data_manager": 0.5,
            "medical_monitor": 0.25,
            "biostatistician": 0.3
          },
          "external_vendors": [
            "CRO (clinical research organization)",
            "central_lab",
            "imaging_core_lab",
            "data_management_vendor"
          ]
        },
        "timeline_estimate_months": {
          "min": 12,
          "typical": 24,
          "max": 48
        },
        "roi_metrics": {
          "primary": "evidence_quality_score",
          "secondary": [
            "regulatory_approval_acceleration",
            "payer_coverage_probability",
            "publication_impact_factor"
          ],
          "expected_roi_range": [
            2.0,
            5.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.9,
            "notes": "Must have governance framework before initiating studies"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "kol_engagement",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOL involvement improves study design and enrollment"
          },
          {
            "pillar_id": "publications",
            "dependency_type": "sequential",
            "strength": 0.85,
            "notes": "Evidence generation feeds publication strategy"
          }
        ],
        "enables": [
          "evidence_interpretation",
          "market_access_support",
          "publications"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.1,
            "timeline_multiplier": 1.05,
            "regulatory_complexity_multiplier": 1.15
          },
          "notes": "MHRA and NHS approval requirements; strong emphasis on health economics data"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "timeline_multiplier": 1.2,
            "regulatory_complexity_multiplier": 1.3
          },
          "notes": "FDA requirements most stringent; highest evidence generation costs globally"
        },
        "EU": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "timeline_multiplier": 1.1,
            "regulatory_complexity_multiplier": 1.2
          },
          "notes": "EMA and member state requirements; HTA evidence requirements vary by country"
        },
        "Eastern_Europe": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.75,
            "timeline_multiplier": 0.9,
            "regulatory_complexity_multiplier": 0.85
          },
          "notes": "Lower costs; variable regulatory maturity across countries"
        },
        "LATAM": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "timeline_multiplier": 0.95,
            "regulatory_complexity_multiplier": 0.8
          },
          "notes": "Cost-effective region for trials; regulatory timelines variable"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "timeline_multiplier": 0.85,
            "regulatory_complexity_multiplier": 0.75
          },
          "notes": "Rapidly developing clinical trial infrastructure; growing regulatory sophistication"
        },
        "Middle_East": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.85,
            "timeline_multiplier": 1.0,
            "regulatory_complexity_multiplier": 0.9
          },
          "notes": "Emerging clinical trial landscape; government support for research infrastructure"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_medical_affairs",
          "medical_strategy_lead"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "budget_approval_threshold_usd": 100000
        },
        "notes": "Core pillar requiring significant investment and long-term commitment"
      }
    },
    {
      "id": "compliance_governance",
      "title": "Compliance & Governance",
      "description": "Design, execute, and manage clinical and non-clinical studies to generate evidence supporting product value proposition and addressing evidence gaps",
      "tags": [
        "clinical_trials",
        "studies",
        "research",
        "data_generation"
      ],
      "maps_strategy": {
        "strategic_intent": "Maintain robust governance to ensure medical activities are ethical, transparent, and compliant across regions, channels, and stakeholders.",
        "scientific_narrative": {
          "core_claim": "Strong governance protects patients, stakeholders, and the organisation while enabling compliant scientific exchange.",
          "supporting_messages": [
            "Rigorous study design addressing key clinical and economic questions",
            "Evidence aligned with regulatory, payer, and clinical stakeholder needs",
            "Prospective data generation to complement existing evidence base"
          ],
          "data_of_interest": [
            "Clinical trial data (efficacy, safety, QoL)",
            "Health economics data (cost-effectiveness, budget impact)",
            "Patient-reported outcomes",
            "Biomarker and mechanistic data"
          ],
          "differentiators": [
            "Evidence quality and regulatory grade",
            "Comprehensive endpoints addressing multiple stakeholder needs",
            "Innovative trial designs (adaptive, pragmatic)"
          ],
          "channel_families": [
            "scientific_publications",
            "congress",
            "field_scientific_exchange"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "prelaunch_T-48_to_T-24",
            "perilaunch_T-24_to_T-12",
            "launch_T-12_to_T0",
            "postlaunch_T0_to_T12",
            "beyond_T12"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Focus on pivotal trial design and execution; early evidence generation for regulatory submissions",
            "perilaunch_T-24_to_T-12": "Complete pivotal studies; initiate post-hoc analyses and supplementary studies",
            "launch_T-12_to_T0": "Finalize study reports; prepare for publication and dissemination",
            "postlaunch_T0_to_T12": "Conduct confirmatory studies and address emerging evidence gaps"
          }
        },
        "evidence": {
          "evidence_dependency": "required",
          "evidence_gaps": [
            "Head-to-head comparator data",
            "Long-term safety and efficacy",
            "Special population data (pediatric, elderly, comorbidities)",
            "Cost-effectiveness in target markets"
          ],
          "prioritized_questions": [
            "What clinical endpoints matter most to regulators, payers, and clinicians?",
            "What study designs provide most credible evidence for stakeholder needs?",
            "How can we generate evidence efficiently while maintaining quality?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "critical",
        "base_priority_score": 0.95,
        "priority_distribution": {
          "mean": 0.95,
          "stddev": 0.08,
          "min": 0.7899999999999999,
          "max": 0.99,
          "confidence_level": "high"
        },
        "dynamic_priority_factors": {
          "regulatory_scrutiny": {
            "weight": 0.3,
            "measurement": "Intensity of external scrutiny and enforcement risk"
          },
          "engagement_risk": {
            "weight": 0.25,
            "measurement": "Risk profile of planned activities and stakeholders"
          },
          "cross_border_complexity": {
            "weight": 0.15,
            "measurement": "Complexity across countries and codes"
          },
          "process_maturity": {
            "weight": 0.2,
            "measurement": "Maturity of governance processes and documentation"
          },
          "resourcing": {
            "weight": 0.1,
            "measurement": "Compliance/Legal/MLR capacity"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "mlr_governance",
          "transparency_reporting",
          "sop_policy_management",
          "audit_readiness"
        ],
        "ineligible_tactic_families": [
          "medical_education",
          "digital_omnichannel"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "tier_2",
        "minimum_confidence_required": 0.8,
        "primary_stakeholder_category_keys": [
          "academia_research",
          "external_experts",
          "regulators"
        ],
        "secondary_stakeholder_category_keys": [
          "market_access_payers",
          "data_tech_partners"
        ],
        "cascade_probability_weights": {
          "evidence_generation": 0.95,
          "advisory_boards": 0.75,
          "data_partnership": 0.7
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "Real-time data streaming studies",
              "API-integrated patient registries",
              "Blockchain-verified study protocols",
              "AI-powered patient matching",
              "Decentralized clinical trials"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.3
          },
          "digital_adopter": {
            "tactics": [
              "Electronic data capture (EDC) systems",
              "Virtual study monitoring",
              "Digital consent processes",
              "Hybrid trial designs",
              "Remote patient monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.1
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional CRF with digital backup",
              "Phone-based patient follow-up",
              "Paper-digital hybrid systems",
              "In-person site visits",
              "Conventional monitoring"
            ],
            "applicability_score": 0.6,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "offline_only": {
            "tactics": [
              "Paper-based data collection",
              "Postal patient surveys",
              "In-person interviews only",
              "Traditional statistical analysis",
              "Physical site monitoring"
            ],
            "applicability_score": 0.4,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "FDA-preapproved study protocols",
              "Independent data monitoring committee",
              "Third-party statistical analysis",
              "Full audit trail documentation",
              "GCP-compliant operations"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.4
          },
          "high": {
            "tactics": [
              "IRB-approved protocols",
              "Regular compliance monitoring",
              "Standard audit procedures",
              "Documentation requirements",
              "Quality assurance protocols"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "medium": {
            "tactics": [
              "Standard ethical approval",
              "Routine monitoring",
              "Basic documentation",
              "Standard reporting",
              "Internal QA reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Minimal approval requirements",
              "Self-monitoring protocols",
              "Streamlined documentation",
              "Simplified reporting",
              "Basic oversight"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_data_sensitivity": {
          "very_high": {
            "tactics": [
              "De-identification at source",
              "Encrypted data transmission",
              "Secure multi-party computation",
              "Zero-knowledge proof protocols",
              "Federated learning approaches"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.35
          },
          "high": {
            "tactics": [
              "Pseudonymization protocols",
              "Encrypted databases",
              "Access control systems",
              "Regular security audits",
              "Privacy-preserving analytics"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "high",
            "cost_multiplier": 1.15
          },
          "medium": {
            "tactics": [
              "Standard data protection",
              "Basic encryption",
              "User authentication",
              "Periodic reviews",
              "Standard privacy measures"
            ],
            "applicability_score": 0.65,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Basic anonymization",
              "Standard security",
              "Simple access controls",
              "Minimal restrictions",
              "Standard data handling"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_cross_border": {
          "restricted": {
            "tactics": [
              "Country-specific protocols",
              "Local PI requirements",
              "Regional data centers",
              "Jurisdiction-specific approvals",
              "Local ethics committees"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "unrestricted": {
            "tactics": [
              "Global protocol harmonization",
              "Central data management",
              "Unified approval processes",
              "Cross-border data sharing",
              "International coordination"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 500000,
          "typical": 2000000,
          "max": 10000000
        },
        "resource_requirements": {
          "ftes": {
            "clinical_operations_lead": 0.5,
            "clinical_project_manager": 1.0,
            "clinical_research_associates": 2.0,
            "data_manager": 0.5,
            "medical_monitor": 0.25,
            "biostatistician": 0.3
          },
          "external_vendors": [
            "CRO (clinical research organization)",
            "central_lab",
            "imaging_core_lab",
            "data_management_vendor"
          ]
        },
        "timeline_estimate_months": {
          "min": 12,
          "typical": 24,
          "max": 48
        },
        "roi_metrics": {
          "primary": "evidence_quality_score",
          "secondary": [
            "regulatory_approval_acceleration",
            "payer_coverage_probability",
            "publication_impact_factor"
          ],
          "expected_roi_range": [
            2.0,
            5.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.9,
            "notes": "Must have governance framework before initiating studies"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "kol_engagement",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOL involvement improves study design and enrollment"
          },
          {
            "pillar_id": "publications",
            "dependency_type": "sequential",
            "strength": 0.85,
            "notes": "Evidence generation feeds publication strategy"
          }
        ],
        "enables": [
          "evidence_interpretation",
          "market_access_support",
          "publications"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.1,
            "timeline_multiplier": 1.05,
            "regulatory_complexity_multiplier": 1.15
          },
          "notes": "MHRA and NHS approval requirements; strong emphasis on health economics data"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "timeline_multiplier": 1.2,
            "regulatory_complexity_multiplier": 1.3
          },
          "notes": "FDA requirements most stringent; highest evidence generation costs globally"
        },
        "EU": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "timeline_multiplier": 1.1,
            "regulatory_complexity_multiplier": 1.2
          },
          "notes": "EMA and member state requirements; HTA evidence requirements vary by country"
        },
        "Eastern_Europe": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.75,
            "timeline_multiplier": 0.9,
            "regulatory_complexity_multiplier": 0.85
          },
          "notes": "Lower costs; variable regulatory maturity across countries"
        },
        "LATAM": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "timeline_multiplier": 0.95,
            "regulatory_complexity_multiplier": 0.8
          },
          "notes": "Cost-effective region for trials; regulatory timelines variable"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "timeline_multiplier": 0.85,
            "regulatory_complexity_multiplier": 0.75
          },
          "notes": "Rapidly developing clinical trial infrastructure; growing regulatory sophistication"
        },
        "Middle_East": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.85,
            "timeline_multiplier": 1.0,
            "regulatory_complexity_multiplier": 0.9
          },
          "notes": "Emerging clinical trial landscape; government support for research infrastructure"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_medical_affairs",
          "medical_strategy_lead"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "budget_approval_threshold_usd": 10000
        },
        "notes": "Governance pillar: enforce SOP/MLR/transparency controls; highest sensitivity to local codes and disclosure rules."
      }
    },
    {
      "id": "data_analytics",
      "title": "Data & Analytics Enablement",
      "description": "Design, execute, and manage clinical and non-clinical studies to generate evidence supporting product value proposition and addressing evidence gaps",
      "tags": [
        "clinical_trials",
        "studies",
        "research",
        "data_generation"
      ],
      "maps_strategy": {
        "strategic_intent": "Enable data-driven planning and measurement via aligned metrics, dashboards, and analytics that support decision-making and optimisation.",
        "scientific_narrative": {
          "core_claim": "Better measurement and analytics improve prioritisation, resource allocation, and demonstrable medical value.",
          "supporting_messages": [
            "Rigorous study design addressing key clinical and economic questions",
            "Evidence aligned with regulatory, payer, and clinical stakeholder needs",
            "Prospective data generation to complement existing evidence base"
          ],
          "data_of_interest": [
            "Clinical trial data (efficacy, safety, QoL)",
            "Health economics data (cost-effectiveness, budget impact)",
            "Patient-reported outcomes",
            "Biomarker and mechanistic data"
          ],
          "differentiators": [
            "Evidence quality and regulatory grade",
            "Comprehensive endpoints addressing multiple stakeholder needs",
            "Innovative trial designs (adaptive, pragmatic)"
          ],
          "channel_families": [
            "scientific_publications",
            "congress",
            "field_scientific_exchange"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "prelaunch_T-48_to_T-24",
            "perilaunch_T-24_to_T-12",
            "launch_T-12_to_T0",
            "postlaunch_T0_to_T12",
            "beyond_T12"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Focus on pivotal trial design and execution; early evidence generation for regulatory submissions",
            "perilaunch_T-24_to_T-12": "Complete pivotal studies; initiate post-hoc analyses and supplementary studies",
            "launch_T-12_to_T0": "Finalize study reports; prepare for publication and dissemination",
            "postlaunch_T0_to_T12": "Conduct confirmatory studies and address emerging evidence gaps"
          }
        },
        "evidence": {
          "evidence_dependency": "required",
          "evidence_gaps": [
            "Head-to-head comparator data",
            "Long-term safety and efficacy",
            "Special population data (pediatric, elderly, comorbidities)",
            "Cost-effectiveness in target markets"
          ],
          "prioritized_questions": [
            "What clinical endpoints matter most to regulators, payers, and clinicians?",
            "What study designs provide most credible evidence for stakeholder needs?",
            "How can we generate evidence efficiently while maintaining quality?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "medium",
        "base_priority_score": 0.55,
        "priority_distribution": {
          "mean": 0.55,
          "stddev": 0.12,
          "min": 0.31000000000000005,
          "max": 0.79,
          "confidence_level": "medium"
        },
        "dynamic_priority_factors": {
          "measurement_gap": {
            "weight": 0.3,
            "measurement": "Gap between desired and current measurement capability"
          },
          "decision_criticality": {
            "weight": 0.25,
            "measurement": "Need for analytics to support key decisions"
          },
          "data_availability": {
            "weight": 0.2,
            "measurement": "Availability/quality of data sources"
          },
          "tooling_maturity": {
            "weight": 0.15,
            "measurement": "Maturity of platforms and integrations"
          },
          "change_management": {
            "weight": 0.1,
            "measurement": "Adoption readiness across teams"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "kpi_frameworks",
          "dashboards_reporting",
          "insight_analytics",
          "data_governance"
        ],
        "ineligible_tactic_families": [
          "medical_education",
          "digital_omnichannel"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "tier_1",
        "minimum_confidence_required": 0.65,
        "primary_stakeholder_category_keys": [
          "academia_research",
          "external_experts",
          "regulators"
        ],
        "secondary_stakeholder_category_keys": [
          "market_access_payers",
          "data_tech_partners"
        ],
        "cascade_probability_weights": {
          "evidence_generation": 0.95,
          "advisory_boards": 0.75,
          "data_partnership": 0.7
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "Real-time data streaming studies",
              "API-integrated patient registries",
              "Blockchain-verified study protocols",
              "AI-powered patient matching",
              "Decentralized clinical trials"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.3
          },
          "digital_adopter": {
            "tactics": [
              "Electronic data capture (EDC) systems",
              "Virtual study monitoring",
              "Digital consent processes",
              "Hybrid trial designs",
              "Remote patient monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.1
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional CRF with digital backup",
              "Phone-based patient follow-up",
              "Paper-digital hybrid systems",
              "In-person site visits",
              "Conventional monitoring"
            ],
            "applicability_score": 0.6,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "offline_only": {
            "tactics": [
              "Paper-based data collection",
              "Postal patient surveys",
              "In-person interviews only",
              "Traditional statistical analysis",
              "Physical site monitoring"
            ],
            "applicability_score": 0.4,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "FDA-preapproved study protocols",
              "Independent data monitoring committee",
              "Third-party statistical analysis",
              "Full audit trail documentation",
              "GCP-compliant operations"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.4
          },
          "high": {
            "tactics": [
              "IRB-approved protocols",
              "Regular compliance monitoring",
              "Standard audit procedures",
              "Documentation requirements",
              "Quality assurance protocols"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "medium": {
            "tactics": [
              "Standard ethical approval",
              "Routine monitoring",
              "Basic documentation",
              "Standard reporting",
              "Internal QA reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Minimal approval requirements",
              "Self-monitoring protocols",
              "Streamlined documentation",
              "Simplified reporting",
              "Basic oversight"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_data_sensitivity": {
          "very_high": {
            "tactics": [
              "De-identification at source",
              "Encrypted data transmission",
              "Secure multi-party computation",
              "Zero-knowledge proof protocols",
              "Federated learning approaches"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.35
          },
          "high": {
            "tactics": [
              "Pseudonymization protocols",
              "Encrypted databases",
              "Access control systems",
              "Regular security audits",
              "Privacy-preserving analytics"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "high",
            "cost_multiplier": 1.15
          },
          "medium": {
            "tactics": [
              "Standard data protection",
              "Basic encryption",
              "User authentication",
              "Periodic reviews",
              "Standard privacy measures"
            ],
            "applicability_score": 0.65,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Basic anonymization",
              "Standard security",
              "Simple access controls",
              "Minimal restrictions",
              "Standard data handling"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_cross_border": {
          "restricted": {
            "tactics": [
              "Country-specific protocols",
              "Local PI requirements",
              "Regional data centers",
              "Jurisdiction-specific approvals",
              "Local ethics committees"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "unrestricted": {
            "tactics": [
              "Global protocol harmonization",
              "Central data management",
              "Unified approval processes",
              "Cross-border data sharing",
              "International coordination"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 500000,
          "typical": 2000000,
          "max": 10000000
        },
        "resource_requirements": {
          "ftes": {
            "clinical_operations_lead": 0.5,
            "clinical_project_manager": 1.0,
            "clinical_research_associates": 2.0,
            "data_manager": 0.5,
            "medical_monitor": 0.25,
            "biostatistician": 0.3
          },
          "external_vendors": [
            "CRO (clinical research organization)",
            "central_lab",
            "imaging_core_lab",
            "data_management_vendor"
          ]
        },
        "timeline_estimate_months": {
          "min": 12,
          "typical": 24,
          "max": 48
        },
        "roi_metrics": {
          "primary": "evidence_quality_score",
          "secondary": [
            "regulatory_approval_acceleration",
            "payer_coverage_probability",
            "publication_impact_factor"
          ],
          "expected_roi_range": [
            2.0,
            5.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.9,
            "notes": "Must have governance framework before initiating studies"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "kol_engagement",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOL involvement improves study design and enrollment"
          },
          {
            "pillar_id": "publications",
            "dependency_type": "sequential",
            "strength": 0.85,
            "notes": "Evidence generation feeds publication strategy"
          }
        ],
        "enables": [
          "evidence_interpretation",
          "market_access_support",
          "publications"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.1,
            "timeline_multiplier": 1.05,
            "regulatory_complexity_multiplier": 1.15
          },
          "notes": "MHRA and NHS approval requirements; strong emphasis on health economics data"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "timeline_multiplier": 1.2,
            "regulatory_complexity_multiplier": 1.3
          },
          "notes": "FDA requirements most stringent; highest evidence generation costs globally"
        },
        "EU": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "timeline_multiplier": 1.1,
            "regulatory_complexity_multiplier": 1.2
          },
          "notes": "EMA and member state requirements; HTA evidence requirements vary by country"
        },
        "Eastern_Europe": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.75,
            "timeline_multiplier": 0.9,
            "regulatory_complexity_multiplier": 0.85
          },
          "notes": "Lower costs; variable regulatory maturity across countries"
        },
        "LATAM": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "timeline_multiplier": 0.95,
            "regulatory_complexity_multiplier": 0.8
          },
          "notes": "Cost-effective region for trials; regulatory timelines variable"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "timeline_multiplier": 0.85,
            "regulatory_complexity_multiplier": 0.75
          },
          "notes": "Rapidly developing clinical trial infrastructure; growing regulatory sophistication"
        },
        "Middle_East": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.85,
            "timeline_multiplier": 1.0,
            "regulatory_complexity_multiplier": 0.9
          },
          "notes": "Emerging clinical trial landscape; government support for research infrastructure"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_medical_affairs",
          "medical_strategy_lead",
          "medical_analytics_lead"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "budget_approval_threshold_usd": 100000
        },
        "notes": "Core pillar requiring significant investment and long-term commitment"
      }
    },
    {
      "id": "congress_presence",
      "title": "Congress Presence & Planning",
      "description": "Design, execute, and manage clinical and non-clinical studies to generate evidence supporting product value proposition and addressing evidence gaps",
      "tags": [
        "clinical_trials",
        "studies",
        "research",
        "data_generation"
      ],
      "maps_strategy": {
        "strategic_intent": "Maximise scientific impact at priority congresses through integrated planning, content strategy, compliant engagement, and insight capture.",
        "scientific_narrative": {
          "core_claim": "Congress execution strengthens scientific credibility and accelerates evidence dissemination and stakeholder engagement.",
          "supporting_messages": [
            "Rigorous study design addressing key clinical and economic questions",
            "Evidence aligned with regulatory, payer, and clinical stakeholder needs",
            "Prospective data generation to complement existing evidence base"
          ],
          "data_of_interest": [
            "Clinical trial data (efficacy, safety, QoL)",
            "Health economics data (cost-effectiveness, budget impact)",
            "Patient-reported outcomes",
            "Biomarker and mechanistic data"
          ],
          "differentiators": [
            "Evidence quality and regulatory grade",
            "Comprehensive endpoints addressing multiple stakeholder needs",
            "Innovative trial designs (adaptive, pragmatic)"
          ],
          "channel_families": [
            "scientific_publications",
            "congress",
            "field_scientific_exchange"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "prelaunch_T-48_to_T-24",
            "perilaunch_T-24_to_T-12",
            "launch_T-12_to_T0",
            "postlaunch_T0_to_T12"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Focus on pivotal trial design and execution; early evidence generation for regulatory submissions",
            "perilaunch_T-24_to_T-12": "Complete pivotal studies; initiate post-hoc analyses and supplementary studies",
            "launch_T-12_to_T0": "Finalize study reports; prepare for publication and dissemination",
            "postlaunch_T0_to_T12": "Conduct confirmatory studies and address emerging evidence gaps"
          }
        },
        "evidence": {
          "evidence_dependency": "required",
          "evidence_gaps": [
            "Head-to-head comparator data",
            "Long-term safety and efficacy",
            "Special population data (pediatric, elderly, comorbidities)",
            "Cost-effectiveness in target markets"
          ],
          "prioritized_questions": [
            "What clinical endpoints matter most to regulators, payers, and clinicians?",
            "What study designs provide most credible evidence for stakeholder needs?",
            "How can we generate evidence efficiently while maintaining quality?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "high",
        "base_priority_score": 0.75,
        "priority_distribution": {
          "mean": 0.75,
          "stddev": 0.1,
          "min": 0.55,
          "max": 0.95,
          "confidence_level": "high"
        },
        "dynamic_priority_factors": {
          "congress_priority": {
            "weight": 0.3,
            "measurement": "Strategic importance of target congresses to the TA"
          },
          "data_milestone_alignment": {
            "weight": 0.25,
            "measurement": "Alignment of data releases to congress timelines"
          },
          "stakeholder_density": {
            "weight": 0.2,
            "measurement": "Density of priority stakeholders attending"
          },
          "execution_complexity": {
            "weight": 0.15,
            "measurement": "Operational complexity and approval timelines"
          },
          "budget": {
            "weight": 0.1,
            "measurement": "Budget availability relative to expected impact"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "congress_strategy",
          "scientific_symposia_support",
          "abstract_planning",
          "congress_insight_capture"
        ],
        "ineligible_tactic_families": [
          "medical_education",
          "digital_omnichannel"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "tier_1",
        "minimum_confidence_required": 0.7,
        "primary_stakeholder_category_keys": [
          "academia_research",
          "external_experts",
          "regulators"
        ],
        "secondary_stakeholder_category_keys": [
          "market_access_payers",
          "data_tech_partners"
        ],
        "cascade_probability_weights": {
          "evidence_generation": 0.95,
          "advisory_boards": 0.75,
          "data_partnership": 0.7
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "Real-time data streaming studies",
              "API-integrated patient registries",
              "Blockchain-verified study protocols",
              "AI-powered patient matching",
              "Decentralized clinical trials"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.3
          },
          "digital_adopter": {
            "tactics": [
              "Electronic data capture (EDC) systems",
              "Virtual study monitoring",
              "Digital consent processes",
              "Hybrid trial designs",
              "Remote patient monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.1
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional CRF with digital backup",
              "Phone-based patient follow-up",
              "Paper-digital hybrid systems",
              "In-person site visits",
              "Conventional monitoring"
            ],
            "applicability_score": 0.6,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "offline_only": {
            "tactics": [
              "Paper-based data collection",
              "Postal patient surveys",
              "In-person interviews only",
              "Traditional statistical analysis",
              "Physical site monitoring"
            ],
            "applicability_score": 0.4,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "FDA-preapproved study protocols",
              "Independent data monitoring committee",
              "Third-party statistical analysis",
              "Full audit trail documentation",
              "GCP-compliant operations"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.4
          },
          "high": {
            "tactics": [
              "IRB-approved protocols",
              "Regular compliance monitoring",
              "Standard audit procedures",
              "Documentation requirements",
              "Quality assurance protocols"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "medium": {
            "tactics": [
              "Standard ethical approval",
              "Routine monitoring",
              "Basic documentation",
              "Standard reporting",
              "Internal QA reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Minimal approval requirements",
              "Self-monitoring protocols",
              "Streamlined documentation",
              "Simplified reporting",
              "Basic oversight"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_data_sensitivity": {
          "very_high": {
            "tactics": [
              "De-identification at source",
              "Encrypted data transmission",
              "Secure multi-party computation",
              "Zero-knowledge proof protocols",
              "Federated learning approaches"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.35
          },
          "high": {
            "tactics": [
              "Pseudonymization protocols",
              "Encrypted databases",
              "Access control systems",
              "Regular security audits",
              "Privacy-preserving analytics"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "high",
            "cost_multiplier": 1.15
          },
          "medium": {
            "tactics": [
              "Standard data protection",
              "Basic encryption",
              "User authentication",
              "Periodic reviews",
              "Standard privacy measures"
            ],
            "applicability_score": 0.65,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Basic anonymization",
              "Standard security",
              "Simple access controls",
              "Minimal restrictions",
              "Standard data handling"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_cross_border": {
          "restricted": {
            "tactics": [
              "Country-specific protocols",
              "Local PI requirements",
              "Regional data centers",
              "Jurisdiction-specific approvals",
              "Local ethics committees"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "unrestricted": {
            "tactics": [
              "Global protocol harmonization",
              "Central data management",
              "Unified approval processes",
              "Cross-border data sharing",
              "International coordination"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 500000,
          "typical": 2000000,
          "max": 10000000
        },
        "resource_requirements": {
          "ftes": {
            "clinical_operations_lead": 0.5,
            "clinical_project_manager": 1.0,
            "clinical_research_associates": 2.0,
            "data_manager": 0.5,
            "medical_monitor": 0.25,
            "biostatistician": 0.3
          },
          "external_vendors": [
            "CRO (clinical research organization)",
            "central_lab",
            "imaging_core_lab",
            "data_management_vendor"
          ]
        },
        "timeline_estimate_months": {
          "min": 12,
          "typical": 24,
          "max": 48
        },
        "roi_metrics": {
          "primary": "evidence_quality_score",
          "secondary": [
            "regulatory_approval_acceleration",
            "payer_coverage_probability",
            "publication_impact_factor"
          ],
          "expected_roi_range": [
            2.0,
            5.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.9,
            "notes": "Must have governance framework before initiating studies"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "kol_engagement",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOL involvement improves study design and enrollment"
          },
          {
            "pillar_id": "publications",
            "dependency_type": "sequential",
            "strength": 0.85,
            "notes": "Evidence generation feeds publication strategy"
          }
        ],
        "enables": [
          "evidence_interpretation",
          "market_access_support",
          "publications"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.1,
            "timeline_multiplier": 1.05,
            "regulatory_complexity_multiplier": 1.15
          },
          "notes": "MHRA and NHS approval requirements; strong emphasis on health economics data"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "timeline_multiplier": 1.2,
            "regulatory_complexity_multiplier": 1.3
          },
          "notes": "FDA requirements most stringent; highest evidence generation costs globally"
        },
        "EU": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "timeline_multiplier": 1.1,
            "regulatory_complexity_multiplier": 1.2
          },
          "notes": "EMA and member state requirements; HTA evidence requirements vary by country"
        },
        "Eastern_Europe": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.75,
            "timeline_multiplier": 0.9,
            "regulatory_complexity_multiplier": 0.85
          },
          "notes": "Lower costs; variable regulatory maturity across countries"
        },
        "LATAM": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "timeline_multiplier": 0.95,
            "regulatory_complexity_multiplier": 0.8
          },
          "notes": "Cost-effective region for trials; regulatory timelines variable"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "timeline_multiplier": 0.85,
            "regulatory_complexity_multiplier": 0.75
          },
          "notes": "Rapidly developing clinical trial infrastructure; growing regulatory sophistication"
        },
        "Middle_East": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.85,
            "timeline_multiplier": 1.0,
            "regulatory_complexity_multiplier": 0.9
          },
          "notes": "Emerging clinical trial landscape; government support for research infrastructure"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_medical_affairs",
          "medical_strategy_lead"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "budget_approval_threshold_usd": 100000
        },
        "notes": "Core pillar requiring significant investment and long-term commitment"
      }
    },
    {
      "id": "rwe_generation",
      "title": "Real-World Evidence (RWE) Generation",
      "description": "Design, execute, and manage clinical and non-clinical studies to generate evidence supporting product value proposition and addressing evidence gaps",
      "tags": [
        "clinical_trials",
        "studies",
        "research",
        "data_generation"
      ],
      "maps_strategy": {
        "strategic_intent": "Generate fit-for-purpose real-world evidence to address post-launch evidence needs, support clinical practice understanding, and inform future strategy.",
        "scientific_narrative": {
          "core_claim": "High-quality RWE complements clinical evidence and reduces uncertainty in real-world populations when generated and communicated responsibly.",
          "supporting_messages": [
            "Rigorous study design addressing key clinical and economic questions",
            "Evidence aligned with regulatory, payer, and clinical stakeholder needs",
            "Prospective data generation to complement existing evidence base"
          ],
          "data_of_interest": [
            "Clinical trial data (efficacy, safety, QoL)",
            "Health economics data (cost-effectiveness, budget impact)",
            "Patient-reported outcomes",
            "Biomarker and mechanistic data"
          ],
          "differentiators": [
            "Evidence quality and regulatory grade",
            "Comprehensive endpoints addressing multiple stakeholder needs",
            "Innovative trial designs (adaptive, pragmatic)"
          ],
          "channel_families": [
            "scientific_publications",
            "congress",
            "field_scientific_exchange"
          ]
        },
        "lifecycle": {
          "relevant_phases": [
            "postlaunch_T0_to_T12",
            "beyond_T12"
          ],
          "phase_notes": {
            "prelaunch_T-48_to_T-24": "Focus on pivotal trial design and execution; early evidence generation for regulatory submissions",
            "perilaunch_T-24_to_T-12": "Complete pivotal studies; initiate post-hoc analyses and supplementary studies",
            "launch_T-12_to_T0": "Finalize study reports; prepare for publication and dissemination",
            "postlaunch_T0_to_T12": "Conduct confirmatory studies and address emerging evidence gaps"
          }
        },
        "evidence": {
          "evidence_dependency": "required",
          "evidence_gaps": [
            "Head-to-head comparator data",
            "Long-term safety and efficacy",
            "Special population data (pediatric, elderly, comorbidities)",
            "Cost-effectiveness in target markets"
          ],
          "prioritized_questions": [
            "What clinical endpoints matter most to regulators, payers, and clinicians?",
            "What study designs provide most credible evidence for stakeholder needs?",
            "How can we generate evidence efficiently while maintaining quality?"
          ]
        }
      },
      "priority_weighting": {
        "base_priority": "high",
        "base_priority_score": 0.75,
        "priority_distribution": {
          "mean": 0.75,
          "stddev": 0.1,
          "min": 0.55,
          "max": 0.95,
          "confidence_level": "high"
        },
        "dynamic_priority_factors": {
          "real_world_uncertainty": {
            "weight": 0.3,
            "measurement": "Uncertainty in real-world effectiveness/safety/use"
          },
          "stakeholder_demand": {
            "weight": 0.25,
            "measurement": "Demand from payers/HCPs for real-world data"
          },
          "data_feasibility": {
            "weight": 0.2,
            "measurement": "Access to data sources and study feasibility"
          },
          "regulatory_interest": {
            "weight": 0.15,
            "measurement": "Regulatory interest in post-marketing evidence"
          },
          "budget_timeline": {
            "weight": 0.1,
            "measurement": "Budget and time feasibility"
          }
        }
      },
      "cascade": {
        "eligible_tactic_families": [
          "observational_studies",
          "registries",
          "rwe_partnerships",
          "post_marketing_research"
        ],
        "ineligible_tactic_families": [
          "medical_education",
          "digital_omnichannel"
        ],
        "supported_metric_levels": [
          "activity",
          "output",
          "outcome",
          "impact"
        ],
        "minimum_metric_level_required": "tier_2",
        "minimum_confidence_required": 0.75,
        "primary_stakeholder_category_keys": [
          "academia_research",
          "external_experts",
          "regulators"
        ],
        "secondary_stakeholder_category_keys": [
          "market_access_payers",
          "data_tech_partners"
        ],
        "cascade_probability_weights": {
          "evidence_generation": 0.95,
          "advisory_boards": 0.75,
          "data_partnership": 0.7
        }
      },
      "tactical_variants": {
        "by_digital_maturity": {
          "digital_native": {
            "tactics": [
              "Real-time data streaming studies",
              "API-integrated patient registries",
              "Blockchain-verified study protocols",
              "AI-powered patient matching",
              "Decentralized clinical trials"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.3
          },
          "digital_adopter": {
            "tactics": [
              "Electronic data capture (EDC) systems",
              "Virtual study monitoring",
              "Digital consent processes",
              "Hybrid trial designs",
              "Remote patient monitoring"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.1
          },
          "digital_reluctant": {
            "tactics": [
              "Traditional CRF with digital backup",
              "Phone-based patient follow-up",
              "Paper-digital hybrid systems",
              "In-person site visits",
              "Conventional monitoring"
            ],
            "applicability_score": 0.6,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "offline_only": {
            "tactics": [
              "Paper-based data collection",
              "Postal patient surveys",
              "In-person interviews only",
              "Traditional statistical analysis",
              "Physical site monitoring"
            ],
            "applicability_score": 0.4,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_compliance_risk": {
          "very_high": {
            "tactics": [
              "FDA-preapproved study protocols",
              "Independent data monitoring committee",
              "Third-party statistical analysis",
              "Full audit trail documentation",
              "GCP-compliant operations"
            ],
            "applicability_score": 0.95,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.4
          },
          "high": {
            "tactics": [
              "IRB-approved protocols",
              "Regular compliance monitoring",
              "Standard audit procedures",
              "Documentation requirements",
              "Quality assurance protocols"
            ],
            "applicability_score": 0.85,
            "implementation_complexity": "high",
            "cost_multiplier": 1.2
          },
          "medium": {
            "tactics": [
              "Standard ethical approval",
              "Routine monitoring",
              "Basic documentation",
              "Standard reporting",
              "Internal QA reviews"
            ],
            "applicability_score": 0.7,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Minimal approval requirements",
              "Self-monitoring protocols",
              "Streamlined documentation",
              "Simplified reporting",
              "Basic oversight"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_data_sensitivity": {
          "very_high": {
            "tactics": [
              "De-identification at source",
              "Encrypted data transmission",
              "Secure multi-party computation",
              "Zero-knowledge proof protocols",
              "Federated learning approaches"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.35
          },
          "high": {
            "tactics": [
              "Pseudonymization protocols",
              "Encrypted databases",
              "Access control systems",
              "Regular security audits",
              "Privacy-preserving analytics"
            ],
            "applicability_score": 0.8,
            "implementation_complexity": "high",
            "cost_multiplier": 1.15
          },
          "medium": {
            "tactics": [
              "Standard data protection",
              "Basic encryption",
              "User authentication",
              "Periodic reviews",
              "Standard privacy measures"
            ],
            "applicability_score": 0.65,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.05
          },
          "low": {
            "tactics": [
              "Basic anonymization",
              "Standard security",
              "Simple access controls",
              "Minimal restrictions",
              "Standard data handling"
            ],
            "applicability_score": 0.5,
            "implementation_complexity": "low",
            "cost_multiplier": 1.0
          }
        },
        "by_cross_border": {
          "restricted": {
            "tactics": [
              "Country-specific protocols",
              "Local PI requirements",
              "Regional data centers",
              "Jurisdiction-specific approvals",
              "Local ethics committees"
            ],
            "applicability_score": 0.75,
            "implementation_complexity": "very_high",
            "cost_multiplier": 1.5
          },
          "unrestricted": {
            "tactics": [
              "Global protocol harmonization",
              "Central data management",
              "Unified approval processes",
              "Cross-border data sharing",
              "International coordination"
            ],
            "applicability_score": 0.9,
            "implementation_complexity": "moderate",
            "cost_multiplier": 1.0
          }
        }
      },
      "resource_estimation": {
        "base_cost_range_usd": {
          "min": 500000,
          "typical": 2000000,
          "max": 10000000
        },
        "resource_requirements": {
          "ftes": {
            "clinical_operations_lead": 0.5,
            "clinical_project_manager": 1.0,
            "clinical_research_associates": 2.0,
            "data_manager": 0.5,
            "medical_monitor": 0.25,
            "biostatistician": 0.3
          },
          "external_vendors": [
            "CRO (clinical research organization)",
            "central_lab",
            "imaging_core_lab",
            "data_management_vendor"
          ]
        },
        "timeline_estimate_months": {
          "min": 12,
          "typical": 24,
          "max": 48
        },
        "roi_metrics": {
          "primary": "evidence_quality_score",
          "secondary": [
            "regulatory_approval_acceleration",
            "payer_coverage_probability",
            "publication_impact_factor"
          ],
          "expected_roi_range": [
            2.0,
            5.0
          ]
        }
      },
      "pillar_dependencies": {
        "prerequisites": [
          {
            "pillar_id": "compliance_governance",
            "dependency_type": "prerequisite",
            "strength": 0.9,
            "notes": "Must have governance framework before initiating studies"
          }
        ],
        "synergistic": [
          {
            "pillar_id": "kol_engagement",
            "dependency_type": "synergistic",
            "strength": 0.75,
            "notes": "KOL involvement improves study design and enrollment"
          },
          {
            "pillar_id": "publications",
            "dependency_type": "sequential",
            "strength": 0.85,
            "notes": "Evidence generation feeds publication strategy"
          }
        ],
        "enables": [
          "evidence_interpretation",
          "market_access_support",
          "publications"
        ]
      },
      "regional_profiles": {
        "UK": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.1,
            "timeline_multiplier": 1.05,
            "regulatory_complexity_multiplier": 1.15
          },
          "notes": "MHRA and NHS approval requirements; strong emphasis on health economics data"
        },
        "US": {
          "priority_level_override": "very_high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.4,
            "timeline_multiplier": 1.2,
            "regulatory_complexity_multiplier": 1.3
          },
          "notes": "FDA requirements most stringent; highest evidence generation costs globally"
        },
        "EU": {
          "priority_level_override": "high",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 1.15,
            "timeline_multiplier": 1.1,
            "regulatory_complexity_multiplier": 1.2
          },
          "notes": "EMA and member state requirements; HTA evidence requirements vary by country"
        },
        "Eastern_Europe": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.75,
            "timeline_multiplier": 0.9,
            "regulatory_complexity_multiplier": 0.85
          },
          "notes": "Lower costs; variable regulatory maturity across countries"
        },
        "LATAM": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.7,
            "timeline_multiplier": 0.95,
            "regulatory_complexity_multiplier": 0.8
          },
          "notes": "Cost-effective region for trials; regulatory timelines variable"
        },
        "SE_Asia_Emerging": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.6,
            "timeline_multiplier": 0.85,
            "regulatory_complexity_multiplier": 0.75
          },
          "notes": "Rapidly developing clinical trial infrastructure; growing regulatory sophistication"
        },
        "Middle_East": {
          "priority_level_override": "medium",
          "relevant_phases_override": [],
          "regional_modifiers": {
            "cost_multiplier": 0.85,
            "timeline_multiplier": 1.0,
            "regulatory_complexity_multiplier": 0.9
          },
          "notes": "Emerging clinical trial landscape; government support for research infrastructure"
        }
      },
      "governance": {
        "status": "approved",
        "review_cadence": "quarterly",
        "last_reviewed_on": "2025-12-30",
        "owner_roles": [
          "head_of_medical_affairs",
          "medical_strategy_lead"
        ],
        "approval_requirements": {
          "mlr_required": true,
          "legal_review_required": true,
          "budget_approval_threshold_usd": 100000
        },
        "notes": "Core pillar requiring significant investment and long-term commitment"
      }
    }
  ]
}